var title_f17_48_18176="Bivalving of torsed ovary 3";
var content_f17_48_18176=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The same ovary seen later in situ with a normal appearance",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 290px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric&nbsp;and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18176=[""].join("\n");
var outline_f17_48_18176=null;
var title_f17_48_18177="Hybridization";
var content_f17_48_18177=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F52164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F52164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hybridization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Wikipedia. Available at: file://en.wikipedia.org/wiki/File:NA_hybrid.svg.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18177=[""].join("\n");
var outline_f17_48_18177=null;
var title_f17_48_18178="Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet (Medical Nutrition Therapy)";
var content_f17_48_18178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet (Medical Nutrition Therapy)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18178/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18178/contributors\">",
"     Lloyd Axelrod, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18178/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18178/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18178/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/48/18178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient calls for an early appointment on the advice of a clinician in a nearby emergency department after being treated for hypoglycemia.",
"   </p>",
"   <p>",
"    The patient, whom you have followed for several years, is a 61 year-old man with a 17-year history of type 2 diabetes. He has been treated with insulin for the last eight years. He checks his fingerstick glucose level only three times per week, and only before breakfast. At his most recent office visit seven weeks ago, the fasting glucose values in his diary were in the range of 95 to 154",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.3 to 8.6",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and the A1C was 7.3 percent.",
"   </p>",
"   <p>",
"    He was treated with NPH insulin 44 units before breakfast,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/45/8922?source=see_link\">",
"     regular insulin",
"    </a>",
"    14 units before supper and NPH insulin 16 units at bedtime. He was also taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    30 mg every morning,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    20 mg at bedtime, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    81 mg a day. He usually avoided concentrated sweets but did not count carbohydrates or follow a specified diabetes nutritional regimen. The patient had been referred to a nutritionist, but had not kept the appointment. At his last visit, his body mass index was 34",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    and he was noted to have non-proliferative retinopathy, distal sensory neuropathy, and modest microalbuminuria.",
"   </p>",
"   <p>",
"    Yesterday, the patient became confused and combative. His wife called 911. The emergency medical technician noted a fingerstick glucose level of 29",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.6",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    gave 25 cc of D5W intravenously and transported him to the emergency department. His mental status returned rapidly to normal. The doctor on duty learned from the patient that he had been having insulin reactions for about 10 days at various times of day. The clinician advised him to reduce all insulin doses by half, and advised him to call you. You agree to see him the next day.",
"   </p>",
"   <p>",
"    At the office visit, you review the patient's interval history. His daughter had urged him to follow the South Beach Diet to lose weight, and given him the book by that name. He immediately started Phase 1 of the diet, in which he eliminated bread, rice, potatoes, pasta, baked goods and fruit. He did not adjust his insulin regimen. The insulin reactions began two days later. You explain to the patient the relationship between his very low carbohydrate diet and the marked fall in insulin requirement he has experienced. He is motivated to improve his diet, but requests your advice.",
"   </p>",
"   <p>",
"    What dietary approach do you recommend? (More than one choice is acceptable.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      You advise him to resume his previous diet and previous insulin doses based upon the fact that his A1c is 7.3 percent, to check his blood glucose values three to four times a day before meals and at bedtime, and to return in five weeks for a regularly scheduled visit. (See",
"      <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a1?source=see_link\">",
"       \"Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A1\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You advise him to continue Phase 1 of the South Beach Diet, to continue his reduced doses of insulin and to return in five weeks for his regularly scheduled visit. (See",
"      <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a2?source=see_link\">",
"       \"Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A2\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You advise him to go immediately to Phase 2 of the South Beach Diet, which involves the reintroduction of certain \"healthy\" carbohydrates that were excluded in the earlier phase such as fruit, whole grain bread, whole grain rice, whole-wheat pasta, and sweet potatoes. You advise him to reduce his insulin doses by about 20 percent compared to his doses at the time of his most recent office visit, ie, to use NPH 35 units before breakfast,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/45/8922?source=see_link\">",
"       regular insulin",
"      </a>",
"      11 units before supper, and NPH 13 units at bedtime. You instruct the patient not to use the Phase 1 diet, even occasionally. You refer him to a nutritionist to learn to count carbohydrates, anticipating a later change from fixed doses of regular insulin to the use of prandial and correction doses of a short- or very short-acting insulin. You advise him to return in five weeks for his regularly scheduled visit. (See",
"      <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a3?source=see_link\">",
"       \"Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A3\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You advise him to start the Atkins Diet, to continue the reduced insulin doses advised by the emergency department clinician and to monitor his urine ketones until they are positive. (See",
"      <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a4?source=see_link\">",
"       \"Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A4\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You advise him to follow a program of lifestyle change. This includes a consistent intake of carbohydrate from fruits, vegetables, whole grains, legumes and low fat milk; limitation of refined sugars; a low intake of saturated fats (&lt;7 percent of total calories) with an emphasis on mono- and poly-unsaturated fats; cholesterol intake &lt;200 mg per day (which necessarily excludes egg yolks); two or more servings of fish per week; varied sources of good-quality protein including meat, poultry, and fish; an increase in dietary fiber; and a 2000 mg a day intake of sodium. This also includes moderate exercise such as walking for 30 to 35 minutes at least five days a week. You refer him to a nutritionist for education and support and to learn to count carbohydrates. (See",
"      <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a5?source=see_link\">",
"       \"Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A5\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4252 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-178.219.2.221-4EAA1F1B94-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18178=[""].join("\n");
var outline_f17_48_18178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a1?source=related_link\">",
"      Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a2?source=related_link\">",
"      Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a3?source=related_link\">",
"      Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a4?source=related_link\">",
"      Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"./interactive-diabetes-case-18-a-61-year-old-man-with-type-2-diabetes-and-a-recent-change-in-diet-a5?source=related_link\">",
"      Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet-A5",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_48_18179="Patient information: My child has diabetes: How will we manage? (The Basics)";
var content_f17_48_18179=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/52/37699\">",
"         Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/26/39331\">",
"         Patient information: Checking your child&rsquo;s blood sugar level (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/40/36483\">",
"         Patient information: Diabetes and diet (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?5/33/5651\">",
"         Patient information: Giving your child insulin (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/14/227\">",
"         Patient information: Hemoglobin A1C tests (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/25/36243\">",
"         Patient information: Keeping your child&rsquo;s blood sugar under control (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/11/38066\">",
"         Patient information: Managing diabetes in school (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/40/22144\">",
"         Patient information: The ABCs of diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/43/692\">",
"         Patient information: Type 1 diabetes (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/58/28579\">",
"         Patient information: Using insulin (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?34/31/35317\">",
"         Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/43/39603\">",
"         Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/20/3397\">",
"         Patient information: Type 1 diabetes mellitus and diet (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: My child has diabetes: How will we manage? (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/my-child-has-diabetes-how-will-we-manage-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H5540860\">",
"      <span class=\"h1\">",
"       What is diabetes?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Diabetes is a disorder that disrupts the way a person&rsquo;s body uses sugar. This causes sugar to build up in the blood. Diabetes is also called &ldquo;diabetes mellitus.&rdquo;",
"     </p>",
"     <p>",
"      There are 2 types of diabetes. People with type 1 diabetes make little or no insulin. Insulin is a hormone that helps the body use sugar. People with type 2 diabetes sometimes also make too little insulin, but more often the problem is that their body doesn&rsquo;t respond to insulin.",
"     </p>",
"     <p>",
"      Most children with diabetes have &ldquo;type 1 diabetes.&rdquo; But some children, especially overweight teenagers, have &ldquo;type 2 diabetes.&rdquo; This article discusses type 1 diabetes.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540875\">",
"      <span class=\"h1\">",
"       Who will take care of my child&rsquo;s diabetes?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Different people will help take care of your child&rsquo;s diabetes. Your child&rsquo;s diabetes team will probably include a doctor, diabetes nurse, dietitian (food expert), and sometimes a mental health counselor and a pharmacist. Your child will see these people on a regular basis.",
"     </p>",
"     <p>",
"      Your child&rsquo;s diabetes team will teach you how to take care of your child&rsquo;s diabetes at home. As your child grows older, he or she should learn more and more about how to take care of his or her diabetes.",
"     </p>",
"     <p>",
"      At school, the school nurse and other staff will help take care of your child&rsquo;s diabetes.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540890\">",
"      <span class=\"h1\">",
"       Will my child need to take medicine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Children with type 1 diabetes need to take a medicine called insulin every day. Insulin works to lower a person&rsquo;s blood sugar level.",
"     </p>",
"     <p>",
"      Insulin usually comes in the form of a shot. Your child can also get insulin from an &ldquo;insulin pump.&rdquo; An insulin pump is a device that slowly delivers insulin to the body. The insulin goes from the pump, through a thin tube, and into the body through a tiny needle put under the skin.",
"     </p>",
"     <p>",
"      There are different types of insulin. Your child will need several insulin doses each day. Your child&rsquo;s diabetes team will:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Teach you about the different types of insulin and when to use them",
"       </li>",
"       <li>",
"        Show you how to give your child an insulin shot or use an insulin pump",
"       </li>",
"       <li>",
"        Teach you how to choose your child&rsquo;s insulin dose &ndash; An insulin dose depends on different factors, such as what your child eats and how active he or she is.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540905\">",
"      <span class=\"h1\">",
"       Will my child need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You will need to check your child&rsquo;s blood sugar level 4 or more times each day. To do this, you will use a device called a &ldquo;blood glucose meter.&rdquo; Your child&rsquo;s doctor or nurse will show you how to use your child&rsquo;s blood glucose meter.",
"     </p>",
"     <p>",
"      Your child&rsquo;s doctor or nurse will also do a blood test called an &ldquo;A1C&rdquo; on a regular basis. This test shows what your child&rsquo;s average blood sugar level has been over the past 2 to 3 months. &nbsp;",
"     </p>",
"     <p>",
"      Your child&rsquo;s doctor or nurse will look at the daily blood sugar levels and the A1C result to know:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        How well-controlled your child&rsquo;s diabetes is",
"       </li>",
"       <li>",
"        If your child&rsquo;s treatment plan needs to be changed",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540920\">",
"      <span class=\"h1\">",
"       Do I have to change my child&rsquo;s diet?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You might need to change what and how much your child eats, and when your child eats. It&rsquo;s important to know what, how much, and when your child eats to make sure that he or she gets the right amount of insulin.",
"     </p>",
"     <p>",
"      Your diabetes team will work with you to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Help you plan healthy meals and snacks for your child",
"       </li>",
"       <li>",
"        Help you make a schedule for meals and snacks",
"       </li>",
"       <li>",
"        Teach you how to choose the correct insulin dose based on what your child eats",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540935\">",
"      <span class=\"h1\">",
"       What else can I do to help my child?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Learn about diabetes &ndash; The more you know about it, the better you can take care of it.",
"       </li>",
"       <li>",
"        Keep your child&rsquo;s blood sugar levels under control &ndash; Levels that are very low or very high can cause serious problems. They need to be treated right away. Also, having high blood sugar levels over many years can damage the kidneys, eyes, nerves, and blood vessels.",
"       </li>",
"       <li>",
"        Learn the symptoms that could mean that your child&rsquo;s blood sugar level is too low or too high &ndash; These symptoms can be different, depending on a child&rsquo;s age.",
"       </li>",
"       <li>",
"        Learn what to do when your child&rsquo;s blood sugar level is too low or too high &ndash; Know when to treat it at home and when to go to the hospital or call 9-1-1 for an ambulance.",
"       </li>",
"       <li>",
"        Have your child wear a medical bracelet or necklace so that others will know about their diabetes in case of an emergency",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540950\">",
"      <span class=\"h1\">",
"       What will my child&rsquo;s life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most children with diabetes lead healthy and active lives. Over time, they learn how to take care of their diabetes on their own.",
"     </p>",
"     <p>",
"      But having diabetes can make children feel sad or worried. If your child is sad or worried, have him or her talk to the doctor, nurse, or mental health counselor.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5540965\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=see_link\">",
"       Patient information: Type 1 diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/33/5651?source=see_link\">",
"       Patient information: Giving your child insulin (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/26/39331?source=see_link\">",
"       Patient information: Checking your child&rsquo;s blood sugar level (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36243?source=see_link\">",
"       Patient information: Keeping your child&rsquo;s blood sugar under control (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/52/37699?source=see_link\">",
"       Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/11/38066?source=see_link\">",
"       Patient information: Managing diabetes in school (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/40/36483?source=see_link\">",
"       Patient information: Diabetes and diet (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/40/22144?source=see_link\">",
"       Patient information: The ABCs of diabetes (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/58/28579?source=see_link\">",
"       Patient information: Using insulin (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/14/227?source=see_link\">",
"       Patient information: Hemoglobin A1C tests (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/31/35317?source=see_link\">",
"       Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/43/39603?source=see_link\">",
"       Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/20/3397?source=see_link\">",
"       Patient information: Type 1 diabetes mellitus and diet (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?17/48/18179?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16597 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-F2EAE850DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18179=[""].join("\n");
var outline_f17_48_18179=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540860\">",
"      What is diabetes?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540875\">",
"      Who will take care of my child&rsquo;s diabetes?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540890\">",
"      Will my child need to take medicine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540905\">",
"      Will my child need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540920\">",
"      Do I have to change my child&rsquo;s diet?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540935\">",
"      What else can I do to help my child?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540950\">",
"      What will my child&rsquo;s life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5540965\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/52/37699?source=related_link\">",
"      Patient information: Carb counting and your child&rsquo;s diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/26/39331?source=related_link\">",
"      Patient information: Checking your child&rsquo;s blood sugar level (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/40/36483?source=related_link\">",
"      Patient information: Diabetes and diet (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/31/35317?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Insulin treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/33/5651?source=related_link\">",
"      Patient information: Giving your child insulin (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/14/227?source=related_link\">",
"      Patient information: Hemoglobin A1C tests (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36243?source=related_link\">",
"      Patient information: Keeping your child&rsquo;s blood sugar under control (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/11/38066?source=related_link\">",
"      Patient information: Managing diabetes in school (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/43/39603?source=related_link\">",
"      Patient information: Self-blood glucose monitoring in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/40/22144?source=related_link\">",
"      Patient information: The ABCs of diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/43/692?source=related_link\">",
"      Patient information: Type 1 diabetes (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/20/3397?source=related_link\">",
"      Patient information: Type 1 diabetes mellitus and diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/58/28579?source=related_link\">",
"      Patient information: Using insulin (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_48_18180="Calciphylaxis retiform purpura";
var content_f17_48_18180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F66308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F66308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Calciphylaxis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retiform purpura and tissue necrosis are present in this patient with calciphylaxis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18180=[""].join("\n");
var outline_f17_48_18180=null;
var title_f17_48_18181="Grade IV traumatic liver injury on computed tomography";
var content_f17_48_18181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F86847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F86847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Grade IV traumatic liver injury on computed tomography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 438px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The CT scan of the abdomen shows a grade&nbsp;III liver injury with multicentric involvement of the left lobe. Narrow CT windows are used to accentuate differences in contrast. There are two lacerations crossing segments II and III (double arrow), a focal hypodense contusion in segment III (arrowhead), and a cystic collection (dashed arrow)&nbsp;traversing segment II and IV.&nbsp; An acute subcapsular hematoma with high density blood is noted posteriorly (short arrow).",
"    <div class=\"footnotes\">",
"     CT: computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18181=[""].join("\n");
var outline_f17_48_18181=null;
var title_f17_48_18182="Venovenous bypass to control liver bleeding";
var content_f17_48_18182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Venovenous bypass to control liver bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 655px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Venovenous bypass diverts venous blood below the level of a clamp on the inferior vena cava through an extracorporeal circuit and into the superior vena cava.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18182=[""].join("\n");
var outline_f17_48_18182=null;
var title_f17_48_18183="Overview of contact lenses";
var content_f17_48_18183=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of contact lenses",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18183/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18183/contributors\">",
"     Michael J Lipson, OD, FAAO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18183/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18183/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18183/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18183/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/48/18183/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;An estimated 40 million people in the United States wear contact lenses, with approximately 38 million soft lens wearers and 2 million rigid gas-permeable lens wearers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/1\">",
"     1",
"    </a>",
"    ]. Surveys show that in recent years the number of new contact lens users is almost equal to the number of contact lens failures.",
"   </p>",
"   <p>",
"    Contact lenses may be categorized by their compositional material, wearing schedule, disposal schedule, permeability, water content, and type of correction (",
"    <a class=\"graphic graphic_table graphicRef67029 \" href=\"UTD.htm?10/23/10620\">",
"     table 1",
"    </a>",
"    ). With many new lens types available, there are alternatives to help most patients achieve comfortable lens wear with clear vision. New types of contact lenses are continually being introduced with the intent to decrease risks of infection, inflammation, and conjunctival trauma while maximizing vision correction and convenience of use [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The types of available contact lenses, indications for their use, and appropriate care to decrease the risk of infection or trauma will be reviewed here. The complications with contact lens use are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29128?source=see_link\">",
"     \"Complications of contact lenses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HYDROPHILIC/SOFT LENSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft lenses account for more than 90 percent of prescribed contact lenses in the United States (",
"    <a class=\"graphic graphic_table graphicRef67029 \" href=\"UTD.htm?10/23/10620\">",
"     table 1",
"    </a>",
"    ) and worldwide (",
"    <a class=\"graphic graphic_table graphicRef57327 \" href=\"UTD.htm?24/19/24891\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Soft lenses are used to correct a variety of refractive errors, including myopia, hyperopia, astigmatism (toric lenses), and presbyopia (multifocal lenses). Not every prescription is available in every material or brand. Certain refractive errors, caused by keratoconus or other corneal distortions, may not be correctable with soft lenses.",
"   </p>",
"   <p>",
"    Soft lenses are generally quite comfortable and easier to adapt to than rigid lenses. Patients wearing soft lenses need regular follow-up care and must be compliant with lens care regimens to avoid serious eye problems (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Guidelines for prevention of infectious keratitis'",
"    </a>",
"    below). Patients who discontinue wearing lenses most commonly complain of lens awareness or dry feeling while wearing lenses. Other reasons include inadequate visual acuity, allergic reactions, and difficulty handling lenses [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft lenses are made of various plastic polymers that absorb water (hydrophilic). These materials differ in terms of oxygen permeability (expressed in Dk units, where D stands for diffusion and k for solubility), water content (varying between 20 and 70 percent water by weight), surface quality (wettability), ultraviolet absorption, and structural consistency (stiffness or modulus). The US Food and Drug Administration (FDA) has developed a system for classifying soft lenses (",
"    <a class=\"graphic graphic_table graphicRef52143 \" href=\"UTD.htm?24/14/24811\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    All soft lenses absorb water, as well as a variety of other substances: chemicals in contact lens solutions, tear secretions, makeup, and airborne chemicals or vapors. Oily substances from the eyelids or facial creams that come in contact with the lens can coat the lens surface.",
"   </p>",
"   <p>",
"    Prior to 1996, the polymer in all soft lenses was primarily 2-hydroxyethyl methacrylate (HEMA)&ndash;based, which is still used in several current lenses. Polymers with silicone hydrogel (SH), which are more highly oxygen permeable, were introduced in 1999 and are now more common in newer types of lenses [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/1\">",
"     1",
"    </a>",
"    ]. Lenses with higher oxygen permeability are generally considered a healthier option [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/6\">",
"     6",
"    </a>",
"    ], although case control studies did not demonstrate that SH lenses decreased the risk of microbial keratitis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/7\">",
"     7",
"    </a>",
"    ] or of nonulcerative contact lens&ndash;related disorders seen in an emergency setting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physical characteristics of different SH lenses are detailed in a table (",
"    <a class=\"graphic graphic_table graphicRef64969 \" href=\"UTD.htm?37/11/38076\">",
"     table 4",
"    </a>",
"    ).",
"    <span class=\"nowrap\">",
"     Dk/t",
"    </span>",
"    is a measure specific to the individual lens, rather than its material, and refers to the oxygen permeability (Dk) of the material normalized for the thickness of the lens (t). The higher the",
"    <span class=\"nowrap\">",
"     Dk/t",
"    </span>",
"    value, the more breathable the lens. Patients using higher",
"    <span class=\"nowrap\">",
"     Dk/t",
"    </span>",
"    lenses develop less corneal edema during all-day or overnight wear, compared to HEMA-based lenses [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/6\">",
"     6",
"    </a>",
"    ]. Other material characteristics include water content, surface quality (wettability), ultraviolet absorption, and modulus (stiffness). The higher modulus lenses will feel stiffer, and lower modulus lenses floppier, when handled.",
"   </p>",
"   <p>",
"    Soft lens materials provide a good medium for microbial growth. Additionally, if patients are not compliant with care techniques, red-eye reactions, discomfort and allergic reactions can occur. Proper disinfection procedures are essential. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Lens care and lens solutions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Other sources of eye irritation are lens deposits (chemical or mechanical), foreign bodies trapped under the contact lens, and allergic reactions to preservatives in the care solutions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29128?source=see_link\">",
"     \"Complications of contact lenses\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Length of wear",
"    </span>",
"    &nbsp;&mdash;&nbsp;The absorption characteristics of soft lenses and their tendency to accumulate surface deposits can affect oxygen permeability and surface quality. Therefore, soft lenses allow only a limited time of safe and healthy usage and should be worn and disposed of on an individually prescribed schedule.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     One day lenses",
"    </span>",
"    &nbsp;&mdash;&nbsp;These lenses are designed for one day wear and are dispensed in a large supply (30 or 90 pair). They are ideal for people who want to wear contact lenses intermittently, for those who place convenience as a high priority, and for those who have sensitivity to disinfecting solutions since they do not require use of disinfecting solutions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Two week disposable",
"    </span>",
"    &nbsp;&mdash;&nbsp;These lenses are the most commonly prescribed in the United States and are worn for a maximum of two weeks. Most should be removed each night and cleaned and disinfected, but some have FDA approval for six days and nights of continuous wear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Monthly disposable",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of these lenses are also worn during the day and removed each night, although some have approval for 30 days of continuous wear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Quarterly disposable",
"    </span>",
"    &nbsp;&mdash;&nbsp;These lenses, designed to be replaced every three months, are generally custom-made lenses for high prescriptions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Special use soft lenses",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Tinted soft lenses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft lenses can be tinted for cosmetic, therapeutic or prosthetic purposes.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cosmetic tints &mdash; Many soft lenses can be made in a variety of colors. The tints may be transparent to enhance natural eye color or can be opaque to dramatically change the color of the iris.",
"     </li>",
"     <li>",
"      Therapeutic tints &mdash; These special tints are used for highly light-sensitive patients or to enhance color perception in patients with color deficiencies. Though these lenses do not fully compensate for color blindness, they are tinted red and worn to help color-deficient patients identify reds and greens more readily.",
"     </li>",
"     <li>",
"      Prosthetic tints &mdash; Soft lenses can be tinted or hand-painted to improve cosmesis in patients with scarred corneas or to create an artificial pupil in patients with aniridia, albinism or",
"      <span class=\"nowrap\">",
"       damaged/distorted",
"      </span>",
"      pupils.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Bandage lenses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft lenses are used as bandage lenses in cases of corneal laceration, corneal exposure injury, and during the healing phase after some ocular surgery such as photorefractive keratectomy (PRK).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Piggyback fitting",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of highly irregular corneal curvature, as in keratoconus, a soft lens is placed on the cornea and a rigid contact lens is placed over it. The soft lens provides a more regular surface for the rigid gas-permeable (RGP) lens to ride upon and also acts to protect the cornea from irritation due to excessive movement of the RGP lens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     RIGID GAS-PERMEABLE LENSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rigid gas-permeable (RGP) contact lenses hold a specific shape although they do have a small amount of flexure. Compared to soft contact lenses, RGP lenses generally provide better visual acuity and are more durable but require longer periods for adaptation. Most wearers can achieve excellent comfort after four to seven days of wear. RGP lenses are generally replaced after two to three years of use.",
"   </p>",
"   <p>",
"    Prior to the development of RGP lenses, \"hard\" lenses were made of a plastic material, polymethylmethacrylate (PMMA). This material provided no oxygen permeability and depended on tear circulation to provide oxygen to the cornea. With the development of RGP lenses, PMMA materials are now rarely used.",
"   </p>",
"   <p>",
"    Because of their rigidity, RGP lenses are often used to achieve optimal visual acuity in patients who have not had satisfactory acuity with soft lenses. RGP lenses are also generally better for those who have some degree of \"dry eyes.\" RGP lenses are also used for overnight corneal reshaping to improve daytime acuity (orthokeratology) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    RGP lenses comprise about 5 to 10 percent of all contact lens fits in the US, including 1 percent for overnight corneal reshaping [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/1\">",
"     1",
"    </a>",
"    ]. There are more than 40 different RGP materials used today. As with soft lens materials, each type of RGP lens has unique characteristics in regards to wettability, oxygen transmission, and flexure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/5\">",
"     5",
"    </a>",
"    ]. Many of these lenses are more gas permeable than soft lenses.",
"   </p>",
"   <p>",
"    Most RGP wearers use their lenses during the day. Some lenses are approved by the US Food and Drug Administration for one week of continuous wear and at least one brand has approval for 30 days of continuous wear.",
"   </p>",
"   <p>",
"    RGP lenses are ordered by the eye care practitioner and made on a custom basis by an RGP lab. Providers can specify various parameters to optimize fit and comfort including diameter, base curve, power, peripheral curves, thickness, edge design, optical zone, as well as material and color.",
"   </p>",
"   <p>",
"    Within the last 15 years, computer-guided lathes have been developed that allow manufacture of highly-customized lenses. RGP lenses can be ordered to fit the inter-palpebral opening (7 to 9 mm), the corneal diameter (10.0 to 11.5 mm), the corneoscleral area (12 to 15 mm), or the sclera (16 to 24 mm).",
"   </p>",
"   <p>",
"    Custom RGP designs may be the only vision correction option for patients with irregular corneal topography who are not correctable with soft lenses or spectacles. Specialty RGP designs include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reverse geometry &mdash; steeper curvature peripherally than centrally",
"     </li>",
"     <li>",
"      Quadrant specific curves &mdash; different curves in each quadrant of the lens",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Toric/bitoric",
"      </span>",
"      &mdash; different curves horizontally versus vertically (on front",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      back surface)",
"     </li>",
"     <li>",
"      Aspheric curves &mdash; placed on front or back surface",
"     </li>",
"     <li>",
"      Multifocal lenses &mdash; eg, aspheric, segmented, concentric",
"     </li>",
"     <li>",
"      Corneal reshaping &mdash; reverse geometry lenses of custom or proprietary design to temporarily change the corneal curvature to improve unaided acuity",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hybrid contact lenses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hybrid contact lenses have an RGP central portion fused to a peripheral soft skirt. The first lens of this type (SoftPerm) was made of very low permeability materials and had limited parameters. A newer version of this innovative design",
"    <span class=\"nowrap\">",
"     (Synergeyes/Duette)",
"    </span>",
"    is comprised of more permeable materials (both central RGP and peripheral soft) and with various parameters to allow fitting over a large range of unique corneal shapes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. These lenses are worn during the day and disposed of after six months of use.",
"   </p>",
"   <p>",
"    The various designs of hybrid lenses can be made to correct for myopia, hyperopia, astigmatism, presbyopia (multifocal design), keratoconus, post-surgical eyes, and other irregular astigmatism cases.",
"   </p>",
"   <p>",
"    Advantages of hybrid lenses are excellent acuity, greater comfort compared with RGP lenses, and a wide range of parameters and designs. Disadvantages of hybrid lenses are more difficult insertion and removal, and higher costs than other lenses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     LENS CARE AND LENS SOLUTIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Caution in contact lens wear",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contact lens wear",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lens care solutions can provoke many eye reactions. Infection risk can be minimized by following proper procedures for contact lens care.",
"   </p>",
"   <p>",
"    Common problems include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/7,14\">",
"     7,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Redness",
"     </li>",
"     <li>",
"      Itching",
"     </li>",
"     <li>",
"      Dryness",
"     </li>",
"     <li>",
"      Allergic reactions",
"     </li>",
"     <li>",
"      Conjunctivitis (microbial, mechanical, allergic or inflammatory) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      CLARE (contact lens-induced acute red eye)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CLARE refers to a sudden red eye reaction in a contact lens wearer of unknown etiology. Possible causes are lens deposits, low grade infection, chemical sensitivity to solution or external chemical contamination of the contact lens.",
"   </p>",
"   <p>",
"    Patients experiencing minor redness or itching without pain or blurred vision should be treated initially with removal of contact lenses and lubricating eye drops (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=see_link\">",
"     artificial tears",
"    </a>",
"    or over-the-counter antihistamine drops). They should be advised to report any increase in severity of symptoms or development of blurred vision or pain. After resolution of minor irritations, future episodes may be prevented by changing the replacement schedule, reducing wearing time, or a change in the lens type or disinfection regimen.",
"   </p>",
"   <p>",
"    Consultation with the eye care provider should be arranged promptly if patients experience blurred vision, pain, or photophobia. More serious conditions associated with contact lenses include corneal ulcers [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/7\">",
"     7",
"    </a>",
"    ], corneal abrasions, and infectious keratitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29128?source=see_link\">",
"     \"Complications of contact lenses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Solutions are used to clean and disinfect contact lenses. Reports of serious infections have been related to contaminated lens cases and inadequate patient disinfectant technique [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10712?source=see_link&amp;anchor=H773301007#H773301007\">",
"     \"Clinical manifestations and diagnosis of Fusarium infection\", section on 'Keratitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4762?source=see_link&amp;anchor=H13571795#H13571795\">",
"     \"Free-living amebas\", section on 'Keratitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Soft lens solutions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Multipurpose solutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multipurpose solutions (MPS) are the most commonly used, accounting for 89 percent of solutions used in the US versus 11 percent for peroxide systems in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/1\">",
"     1",
"    </a>",
"    ]. MPS are intended to be \"all-in-one\" solutions that are used to rinse, clean, disinfect, and store lenses during their overnight soaking. Success with MPS depends on patient compliance with directions, particularly in regard to sufficient rinsing or, preferably, using a rub technique to achieve adequate disinfection [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Individual patient tolerance is variable, and some find that multipurpose solutions provoke an allergic or toxic reaction when exposed to the eye. Available multipurpose solutions in the US are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef59505 \" href=\"UTD.htm?28/34/29228\">",
"     table 5",
"    </a>",
"    ). Generic versions are also available at various retailers.",
"   </p>",
"   <p>",
"    While MPS offer several conveniences compared to other contact lens solutions (ready availability, one bottle, ease for travel) MPS are also more likely to cause allergic or sensitivity reactions, and corneal staining is more prevalent than with peroxide systems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Peroxide systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peroxide systems have gained in popularity over the last few years. They use",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    to disinfect and passively oxidize surface deposits. These systems require that the peroxide solution be \"neutralized\" prior to lens use, and different techniques (one or two-step) are used for accomplishing this. Commercially available peroxide systems in the US are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef59505 \" href=\"UTD.htm?28/34/29228\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Peroxide disinfection, compared to MPS, provides no direct exposure to preservatives and there is a lower likelihood of sensitivity reactions. Lens cleaning is passive, by oxidation, and there is less risk for noncompliance resulting in infection. However, peroxide systems lack the convenience factors of MPS, are more difficult to travel with, and pose the potential for irritation from accidental exposure to non-neutralized solution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Guidelines for prevention of infectious keratitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following national and international reports of Acanthamoeba keratitis and Fusarium keratitis, the US Food and Drug Administration (FDA) reviewed proper care of contact lenses. Citing the risk of eye infections and corneal ulcers, with the potential to cause blindness, the FDA has issued recommendations and guidelines for the safe use of contact lenses and associated care products [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/18\">",
"     18",
"    </a>",
"    ]. These recommendations follow:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Always wash your hands before handling contact lenses to reduce the chance of getting an infection.",
"     </li>",
"     <li>",
"      Remove the lenses immediately and consult your eye care professional if your eyes become red, irritated, or your vision changes.",
"     </li>",
"     <li>",
"      Always follow the directions of your eye care professional and all labeling instruction for proper use of contact lenses and lens care products.",
"     </li>",
"     <li>",
"      Use contact lens products and solutions recommended by your eye care professional.",
"     </li>",
"     <li>",
"      Do not use contact lens solutions that have gone beyond the expiration or discard date.",
"     </li>",
"     <li>",
"      Rub and rinse your contact lenses as directed by your eye care professional.",
"     </li>",
"     <li>",
"      Clean and disinfect your lenses properly following all labeling instructions provided with your lens care products.",
"     </li>",
"     <li>",
"      Do not \"top-off\" the solutions in your case. Always discard all of the left over contact lens solution after each use. Never reuse any lens solution.",
"     </li>",
"     <li>",
"      Never use non-sterile water (distilled water, tap water or any homemade saline solution). Exposure of contact lenses to water has been associated with Acanthamoeba keratitis, a corneal infection that is resistant to treatment and cure.",
"     </li>",
"     <li>",
"      Do not put your lenses in your mouth to wet them. Saliva is not a sterile solution.",
"     </li>",
"     <li>",
"      Clean, rinse, and air-dry your lens case each time lenses are removed. You may want to flip over your lens case while air drying so excess solution may drain out of the case. Contact lens cases can be a source of bacterial growth.",
"     </li>",
"     <li>",
"      Replace your contact lens storage case every three to six months.",
"     </li>",
"     <li>",
"      Do not transfer contact lens solutions into smaller travel size containers. This can affect the sterility of the solution which can lead to an eye infection. Transferring solutions into smaller size containers may also leave consumers open to accidentally using a solution not intended for the eyes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A synopsis of these recommendations is presented in a table (",
"    <a class=\"graphic graphic_table graphicRef77651 \" href=\"UTD.htm?13/43/14012\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Rigid gas-permeable solutions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solutions to be used with RGP lenses vary in viscosity, wetting agent, and preservatives. One to three bottles contain solutions designed for",
"    <span class=\"nowrap\">",
"     wetting/conditioning,",
"    </span>",
"    disinfecting, and cleaning. Available solutions in the US are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef59505 \" href=\"UTD.htm?28/34/29228\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Lubricating drops",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous brands of drops that are designed to be used with contact lenses as lubricants at frequencies varying from once per day to hourly. These may be labeled as \"contact lens drops,\"",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=see_link\">",
"     artificial tears",
"    </a>",
"    , or lubricating drops. Available lubricants differ in their viscosity and whether or not they are preserved, and individual patient preference and tolerance will determine which is most acceptable. Compatibility with patient's eyes, individual contact lens brand, and other solutions patients use are also factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CONTACT LENS FITTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contact lens fitting should be done by experienced clinicians who may be optometrists or ophthalmologists. A thorough pre-fitting evaluation can identify risk factors and target the best lens and lens care combination to provide long-term comfort, good vision, and easy maintenance.",
"   </p>",
"   <p>",
"    A thorough pre-fitting evaluation should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Refraction and visual acuity",
"     </li>",
"     <li>",
"      Keratometry",
"     </li>",
"     <li>",
"      Corneal topography",
"     </li>",
"     <li>",
"      Biomicroscopic evaluation of the cornea, conjunctiva, and eyelids",
"     </li>",
"     <li>",
"      Empirical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      diagnostic fitting",
"     </li>",
"     <li>",
"      Instruction about",
"      <span class=\"nowrap\">",
"       insertion/removal,",
"      </span>",
"      lens care, and solutions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After initial dispensing, follow-up evaluations should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Biomicroscopic evaluation of the cornea, conjunctiva, and eyelids with and without contact lenses in place",
"     </li>",
"     <li>",
"      Visual acuity",
"     </li>",
"     <li>",
"      Review of care, handling, and disinfection procedures",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Follow-up frequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;New contact lens wearers should generally be seen within the first week, at one month, six months, and annually thereafter. This frequency may vary with the type of lens, wearing schedule, and condition being treated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     INSERTION AND REMOVAL TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Insertion of all types of lenses involves, with clean hands, placing the prepared lens directly on the center of the cornea while holding the lids and lashes to create an opening large enough to clear the diameter of the lens.",
"   </p>",
"   <p>",
"    Removal techniques vary with the lens type:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Soft lenses are removed by pinching the edges of the lens at the four and eight o'clock positions with the thumb and index finger while holding the upper lid out of the way. Inserting a drop of wetting solution or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=see_link\">",
"       artificial tears",
"      </a>",
"      makes removal easier.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the lens is not readily removed, it is possible the lens is in the eye but not on center. The most likely place to find the dislocated lens is under the upper lid (usually folded). To check for this, have the patient look straight down while holding the upper lid up as high as possible. If found, the lens can be pinched out from there. It may be necessary to evert the lid to find a lens that has adhered to the inner surface of the upper lid.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rigid gas-permeable lenses can be removed with a rubbery contact lens removal tool (suction cup) or by manipulating the upper and lower lid simultaneously together against the edges of the lens. If an RGP lens is off-center, it is best to try to manipulate the lens position through the closed lids to a position of easy access, usually the temporal sclera, and then use the suction cup device.",
"     </li>",
"     <li>",
"      Hybrid lenses are removed similar to soft lenses, except that the area of pinching must be smaller, at the edge of the soft portion of the lens. Pinch the soft portion with both fingers at the six o'clock position. With this lens, it is critical that the upper lid be held away from the surface of the lens to allow for removal. Again, lubricating drops inserted in the eye can help remove a lens that is not coming out easily.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     FUTURE DEVELOPMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Investigation is ongoing to develop new designs, materials, and applications for contact lenses.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Drug delivery systems &mdash; Lenses impregnated with drugs for slow sustained release are being evaluated for anti-infective, anti- inflammatory, and pressure-lowering indications [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/19-21\">",
"       19-21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Newer coatings &mdash; Different coatings are under investigation to make lenses more resistant to bacterial adhesion and to minimize mucous or protein deposits [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Multifocal lenses &mdash; New lens designs in various materials aim to improve acuity for distance and near vision [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/24,25\">",
"       24,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Aberration-correcting contact lens &mdash; Based on wavefront refractive and corneal analysis, these lenses are wavefront-generated to provide a customized correction and improve visual acuity over traditional optics [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18183/abstract/26-28\">",
"       26-28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Contact lenses may be categorized by their compositional material, wearing schedule, disposal schedule, permeability, water content, and type of correction (",
"      <a class=\"graphic graphic_table graphicRef67029 \" href=\"UTD.htm?10/23/10620\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Soft lenses can be classified by a number of properties, including oxygen permeability, water content, and structural consistency (",
"      <a class=\"graphic graphic_table graphicRef52143 \" href=\"UTD.htm?24/14/24811\">",
"       table 3",
"      </a>",
"      ). Silicon hydrogel lenses, with increased oxygen permeability, are often considered preferable. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Hydrophilic/soft lenses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rigid gas-permeable (RGP) contact lenses hold a specific shape although they do have a small amount of flexure. Compared to soft contact lenses, RGP lenses generally provide better visual acuity and are more durable but require longer periods for adaptation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Rigid gas-permeable lenses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multipurpose solutions are the most commonly used solutions in the United States to rinse, clean, disinfect, and store lenses during their overnight soaking. Compared to other solutions, multipurpose solutions are more convenient but more likely to cause allergic or sensitivity reactions. Peroxide disinfection systems provides no direct exposure to preservatives, though are somewhat less convenient. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Multipurpose solutions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Peroxide systems'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Proper use of contact lenses and hygienic recommendations were issued in a guideline from the US Food and Drug Administration, after review of the factors contributing to outbreaks of Acanthamoeba keratitis and Fusarium keratitis (",
"      <a class=\"graphic graphic_table graphicRef77651 \" href=\"UTD.htm?13/43/14012\">",
"       table 6",
"      </a>",
"      ). These recommendations include hand washing, discarding outdated solutions, following instructions for disinfection, only using manufacture-prepared solutions in their original bottles, not saliva, as a lubricant, cleaning cases and replacing them every three to six months. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Guidelines for prevention of infectious keratitis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Nichols J. Contact Lenses 2008. Contact Lens Spectrum 2009; 1:24. Available at: file://www.clspectrum.com/article.aspx?article=102473 (Accessed on November 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/2\">",
"      Foulks GN. Prolonging contact lens wear and making contact lens wear safer. Am J Ophthalmol 2006; 141:369.",
"     </a>",
"    </li>",
"    <li>",
"     Mack C. Contact Lenses 2007: A look back at contact lens events of 2007 including prescribing trends, product recalls and launches, compliance issue, mergers and corneal staining. Contact Lens Spectrum 2008. Available at: file://www.clspectrum.com/article.aspx?article=101240 (Accessed on November 01, 2011).",
"    </li>",
"    <li>",
"     Morgan PB, Woods CA, Knajian R, et al. International Contact Lens Prescribing in 2007: Our annual review of international prescribing trends reports on close to 20,000 prospectively conducted fits in 27 countries. Contact Lens Spectrum 2008. Available at: file://www.clspectrum.com/article.aspx?article=101241 (Accessed on November 01, 2011).",
"    </li>",
"    <li>",
"     Soft Contact Lenses: Hydrogel and Silicone Hydrogel Lens General Considerations. Contact Lens Spectrum 2008. Available at: file://www.clspectrum.com/article.aspx?article=&amp;loc=archive\2008\july\supplements\cls_class\cls_july_class_suppl_a02.html (Accessed on November 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/6\">",
"      Stern J, Wong R, Naduvilath TJ, et al. Comparison of the performance of 6- or 30-night extended wear schedules with silicone hydrogel lenses over 3 years. Optom Vis Sci 2004; 81:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/7\">",
"      Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology 2008; 115:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/8\">",
"      Radford CF, Minassian D, Dart JK, et al. Risk factors for nonulcerative contact lens complications in an ophthalmic accident and emergency department: a case-control study. Ophthalmology 2009; 116:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/9\">",
"      Jupiter DG, Katz HR. Management of irregular astigmatism with rigid gas permeable contact lenses. CLAO J 2000; 26:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/10\">",
"      Swarbrick HA, Wong G, O'Leary DJ. Corneal response to orthokeratology. Optom Vis Sci 1998; 75:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/11\">",
"      Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft disposable contact lenses: vision-related quality-of-life differences from a randomized clinical trial. Optom Vis Sci 2005; 82:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/12\">",
"      Lipson MJ, Musch DC. Synergeyes versus soft toric lenses: vision-related quality of life. Optom Vis Sci 2007; 84:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/13\">",
"      Nau AC. A comparison of synergeyes versus traditional rigid gas permeable lens designs for patients with irregular corneas. Eye Contact Lens 2008; 34:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/14\">",
"      Lemp MA. Contact lenses and allergy. Curr Opin Allergy Clin Immunol 2008; 8:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/15\">",
"      Patel A, Hammersmith K. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol 2008; 19:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/16\">",
"      Koffler BH, Karpecki PM. Positive aspects of the use of multipurpose disinfection solutions. Arch Ophthalmol 2009; 127:1540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/17\">",
"      Cohen EJ. Contact lens solutions: part of the problem. Arch Ophthalmol 2009; 127:1544.",
"     </a>",
"    </li>",
"    <li>",
"     FDA Website. Available at: www.fda.gov/cdrh/contactlenses/lenslist.html (Accessed on November 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/19\">",
"      Hiratani H, Alvarez-Lorenzo C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 2004; 25:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/20\">",
"      Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 2004; 45:2342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/21\">",
"      Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci 2009; 50:3346.",
"     </a>",
"    </li>",
"    <li>",
"     Valint, PL, et al. Plasma Surface Treatment of Slicone Hydrogel Contact Lenses with a Flexible Carbon Coating. US Patent # 6,213,604 B1 April 10, 2001.",
"    </li>",
"    <li>",
"     Carney et al Medical Devices Having Antimicrobial coatings. Theron US Patent application # 10/722,256 July 15, 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/24\">",
"      Guillon M, Maissa C, Cooper P, et al. Visual performance of a multi-zone bifocal and a progressive multifocal contact lens. CLAO J 2002; 28:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/25\">",
"      Pujol J, Gispets J, Arjona M. Optical performance in eyes wearing two multifocal contact lens designs. Ophthalmic Physiol Opt 2003; 23:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/26\">",
"      Guirao A, Porter J, Williams DR, Cox IG. Calculated impact of higher-order monochromatic aberrations on retinal image quality in a population of human eyes. J Opt Soc Am A Opt Image Sci Vis 2002; 19:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/27\">",
"      de Brabander J, Chateau N, Marin G, et al. Simulated optical performance of custom wavefront soft contact lenses for keratoconus. Optom Vis Sci 2003; 80:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18183/abstract/28\">",
"      Thibos LN, Cheng X, Bradley A. Design principles and limitations of wave-front guided contact lenses. Eye Contact Lens 2003; 29:S167.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6906 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-189.41.172.26-E56BECDC24-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18183=[""].join("\n");
var outline_f17_48_18183=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HYDROPHILIC/SOFT LENSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Length of wear",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - One day lenses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Two week disposable",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Monthly disposable",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Quarterly disposable",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Special use soft lenses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Tinted soft lenses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Bandage lenses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Piggyback fitting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      RIGID GAS-PERMEABLE LENSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hybrid contact lenses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      LENS CARE AND LENS SOLUTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Caution in contact lens wear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Soft lens solutions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Multipurpose solutions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Peroxide systems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Guidelines for prevention of infectious keratitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Rigid gas-permeable solutions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Lubricating drops",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CONTACT LENS FITTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Follow-up frequency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      INSERTION AND REMOVAL TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      FUTURE DEVELOPMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6906\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6906|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/23/10620\" title=\"table 1\">",
"      2011 US soft lens market",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/19/24891\" title=\"table 2\">",
"      2011 soft lens use by type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/14/24811\" title=\"table 3\">",
"      FDA classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/11/38076\" title=\"table 4\">",
"      Silicone hydrogel contact lens properties",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/34/29228\" title=\"table 5\">",
"      Contact lens solutions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/43/14012\" title=\"table 6\">",
"      FDA safe use guidelines",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/29/10712?source=related_link\">",
"      Clinical manifestations and diagnosis of Fusarium infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29128?source=related_link\">",
"      Complications of contact lenses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/41/4762?source=related_link\">",
"      Free-living amebas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_48_18184="Bivalirudin: Drug information";
var content_f17_48_18184=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Bivalirudin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?37/23/38259?source=see_link\">",
"    see \"Bivalirudin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F141778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Angiomax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F141779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Angiomax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F141795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticoagulant, Thrombin Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F141781\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     If clinically indicated, a glycoprotein IIb/IIIa inhibitor may be concomitantly administered during percutaneous coronary intervention (PCI). In addition to aspirin, concomitant administration of clopidogrel or prasugrel is also recommended for patients undergoing PCI (King, 2005; Kushner, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      PTCA/PCI with or without HIT/HITTS:",
"     </b>",
"     I.V.: Initial: 0.75 mg/kg bolus immediately prior to procedure, followed by 1.75 mg/kg/hour for the duration of procedure and up to 4 hours postprocedure if needed; may determine ACT 5 minutes after bolus dose; may administer additional bolus of 0.3 mg/kg if necessary. If continued anticoagulation is needed after the initial 4-hour postprocedure infusion, the infusion may be continued at 0.2 mg/kg/hour for up to an additional 20 hours (U.S. labeling) or 0.25 mg/kg/hour for 4-12 hours post procedure (Canadian labeling).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) (moderate-high risk) undergoing early invasive strategy:",
"     </b>",
"     <i>",
"      U.S. unlabeled dose:",
"     </i>",
"     I.V.: Initial: 0.1 mg/kg bolus, followed by 0.25 mg/kg/hour. Once PCI is determined to be necessary, give an additional bolus of 0.5 mg/kg and increase infusion rate to 1.75 mg/kg/hour; may discontinue at end of procedure or continue for up to 4 hours postprocedure if necessary (Stone, 2006). If after angiography, cardiac surgery is deemed necessary, discontinue bivalirudin 3 hours prior to surgery and dose with unfractionated heparin per institutional practice. If medical management is the decided treatment approach, may either discontinue bivalirudin or continue at 0.25 mg/kg/hour for up to 72 hours (Jneid, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Initial: 0.1 mg/kg bolus, followed by 0.25 mg/kg/hour for up to 72 hours if patient is medically managed. If PCI is determined to be necessary, give an additional bolus of 0.5 mg/kg and increase infusion rate to 1.75 mg/kg/hour; may resume infusion at 0.25 mg/kg/hour for 4-12 hours following PCI if necessary.  If coronary artery bypass graft (CABG) surgery is deemed necessary, discontinue bivalirudin infusion 1 hour prior to CABG (on-pump) surgery and dose with unfractionated heparin or continue infusion until time of CABG (off-pump) surgery then give 0.5 mg/kg bolus and increase infusion rate to 1.75 mg/kg/hour until end of surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      STEMI undergoing primary PCI:",
"     </b>",
"     <i>",
"      U.S. unlabeled use:",
"     </i>",
"     I.V.: Initial: 0.75 mg/kg bolus, followed by 1.75 mg/kg/hour for the duration of procedure; may continue postprocedure at a reduced dose if clinically indicated (Stone, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      If patient received unfractionated heparin (UFH) prior to procedure and bivalirudin is the desired anticoagulant:",
"     </i>",
"     Discontinue heparin if infusing; without measurement of ACT, may initiate bivalirudin &ge;30 minutes after the last UFH bolus but before PCI occurs (Stone, 2008). Switching patients from UFH to bivalirudin has been shown to be safe compared to continuing with UFH and as needed glycoprotein IIb/IIIa inhibition; median time from prerandomization UFH bolus to bivalirudin administration within the HORIZONS-AMI trial was 64 &plusmn; 61 minutes (Dangas, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Initial: 0.1 mg/kg bolus, followed by 0.25 mg/kg/hour for up to 72 hours if patient is medically managed. If PCI is determined to be necessary, give an additional bolus of 0.5 mg/kg and increase infusion rate to 1.75 mg/kg/hour; may resume infusion at 0.25 mg/kg/hour for 4-12 hours following PCI if necessary.  If coronary artery bypass graft (CABG) surgery is deemed necessary, discontinue bivalirudin infusion 1 hour prior to CABG (on-pump) surgery and dose with unfractionated heparin or continue infusion until time of CABG (off-pump) surgery then give 0.5 mg/kg bolus and increase infusion rate to 1.75 mg/kg/hour until end of surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Cardiac surgery in patients with acute or subacute heparin-induced thrombocytopenia, urgent surgery required:",
"     </b>",
"     <i>",
"      U.S. unlabeled use",
"     </i>",
"     (Linkins, 2012): I.V.: Intraoperative:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Off-pump:",
"      </i>",
"     </b>",
"     Initial bolus: 0.75 mg/kg, followed by continuous infusion 1.75 mg/kg/hour to maintain ACT &gt;300 seconds (Dyke, 2007).  If patient needs to go on-pump, Canadian labeling recommends an additional 0.25 mg/kg bolus and increasing the infusion rate to 2.5 mg/kg/hour.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      <i>",
"       On-pump:",
"      </i>",
"     </b>",
"     Initial bolus: 1 mg/kg, followed by continuous infusion 2.5 mg/kg/hour; 50 mg bolus added to priming solution of cardiopulmonary bypass (CPB) circuit. Additional boluses of 0.1-0.5 mg/kg may be given to maintain ACT &gt;2.5 times baseline ACT.",
"     <b>",
"      Note:",
"     </b>",
"     Special maneuvers needed to prevent stasis and consequent clotting within CPB circuit during or after surgery (Koster, 2007). Per Canadian labeling, after completion of CPB, provision to allow recirculation of the circuit may be done by administering 50 mg",
"     <b>",
"      into the circuit",
"     </b>",
"     followed by a continuous infusion of 50 mg/hour",
"     <b>",
"      into the circuit.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     Pre -and post-cardiac surgery administration: Initial bolus: 0.1 mg/kg, followed by continuous infusion 0.2 mg/kg/hour for up to 48 hours prior to surgery or for up to 14 days after surgery; maintain aPTT 1.5-2.5 times baseline aPTT.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Heparin-induced thrombocytopenia (HIT) (unlabeled use):",
"     </b>",
"     I.V.: Initial dose: 0.15-0.2 mg/kg/hour; adjust to aPTT 1.5-2.5 times baseline value (Linkins, 2012).",
"     <b>",
"      Note:",
"     </b>",
"     Although the use of bivalirudin is not a currently recommended treatment for HIT due to insufficient evidence, the American College of Chest Physicians recommends overlapping administration of warfarin for a minimum of 5 days until INR is within target range; recheck INR after the non-heparin anticoagulant effect has dissipated (Linkins, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F141782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing. No dosage adjustment is needed in elderly patients with normal renal function. Puncture site hemorrhage and catheterization site hemorrhage were seen in more patients &ge;65 years of age than in patients &lt;65 years of age.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F141783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Infusion dose should be reduced based on degree of renal impairment. Initial bolus dose remains unchanged. Monitor activated coagulation time (ACT) or aPTT depending on indication.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      For use in PCI:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      U.S. labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute: No adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: Decrease infusion rate to 1 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Dialysis-dependent patients (off dialysis during administration): Decrease infusion rate to 0.25 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hemodialysis: Approximately 25% removed during hemodialysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     Check ACT following dose alterations at 5 and 45 minutes in renally impaired patients. If ACT &le;250 seconds give additional bolus 0.3 mg/kg and double infusion rate to maintain ACT ~350 seconds; if ACT 250-300 seconds give additional bolus 0.3 mg/kg to maintain ACT ~350 seconds.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute: No adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: Decrease infusion rate to 1 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Dialysis-dependent patients (off dialysis during administration): Decrease infusion rate to 0.25 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      For use in cardiac surgery:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Canadian labeling:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;30 mL/minute: No adjustment required; monitor ACT.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: No dosage adjustment provided in manufacturer&rsquo;s labeling; has not been studied; monitor ACT.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      For use in HIT:",
"     </b>",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling for this population; however, the following dose ranges have been observed in small retrospective observational studies (Kiser 2006; Kiser, 2008; Tsu, 2011). Of note, critically-ill patients comprised a significant proportion of patients in these observational studies. The following dose recommendations are based on the mean dose achieving aPTT goal within these studies; overlaps may exist;",
"     <b>",
"      Note:",
"     </b>",
"     The Cockcroft-Gault equation was used in all studies to define creatinine clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;60 mL/minute: 0.13 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-60 mL/minute: 0.08-0.1 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: 0.04-0.05 mg/kg/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intermittent hemodialysis (IHD): 0.07 mg/kg/hour (Tsu, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CRRT (eg, CVVH or CVVHDF): 0.03-0.07 mg/kg/hour (Kiser, 2006; Tsu, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Sustained low-efficiency daily diafiltration (SLEDD):  0.09 mg/kg/hour (Tsu, 2011)",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F141784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F141758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Angiomax&reg;: 250 mg [contains sodium 12.5 mg/vial]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F141744\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F141760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.V. administration only.",
"    </p>",
"   </div>",
"   <div class=\"block uica drugH1Div\" id=\"F14471292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     250 mg in 500 mL (concentration: 0.5 mg/mL)",
"     <b>",
"      or",
"     </b>",
"     250 mg in 50 mL (concentration: 5 mg/mL) of D",
"     <sub>",
"      5",
"     </sub>",
"     W or NS",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F141802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, SWFI",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Abciximab, alfentanil, amikacin, aminophylline, ampicillin, ampicillin/sulbactam, atropine, azithromycin, aztreonam, bumetanide, butorphanol, calcium gluconate, cefazolin, cefepime, cefotaxime, cefotetan, cefoxitin, ceftazidime, cefuroxime, cimetidine, ciprofloxacin, clindamycin, dexamethasone sodium phosphate, digoxin, diltiazem, diphenhydramine, dopamine, doxycycline, droperidol, enalaprilat, ephedrine, epinephrine, epoprostenol, eptifibatide, erythromycin lactobionate, esmolol, famotidine, fentanyl, fluconazole, furosemide, gentamicin, haloperidol, heparin, hydrocortisone sodium succinate, hydromorphone, inamrinone, isoproterenol, labetalol, levofloxacin, lidocaine, lorazepam, magnesium sulfate, mannitol, meperidine, methylprednisolone sodium succinate, metoclopramide, metoprolol, metronidazole, midazolam, milrinone, morphine, nalbuphine, nitroglycerin, nitroprusside, norepinephrine, phenylephrine, piperacillin, piperacillin/tazobactam, potassium chloride, procainamide, promethazine, ranitidine, sodium bicarbonate, sufentanil, theophylline, thiopental, ticarcillin/clavulanate, tirofiban, tobramycin, trimethoprim/sulfamethoxazole, verapamil, warfarin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Alteplase, amiodarone, amphotericin B, chlorpromazine, diazepam, prochlorperazine, reteplase, vancomycin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftriaxone, dobutamine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible",
"     </b>",
"     with ceftriaxone.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F141759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Anticoagulant used in conjunction with aspirin for patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI) with provisional glycoprotein IIb/IIIa inhibitor; anticoagulant used in conjunction with aspirin for patients undergoing PCI with (or at risk of) heparin-induced thrombocytopenia (HIT) / thrombosis syndrome (HITTS)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional uses (not in U.S. labeling): In conjunction with aspirin for treatment of patients with ST-elevation myocardial infarction (STEMI) undergoing primary PCI; anticoagulant with or without aspirin in patients undergoing cardiac surgery with (or at risk of) heparin-induced thrombocytopenia (HIT) / thrombosis syndrome (HITTS)",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F5631572\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Heparin-induced thrombocytopenia (HIT); ST-elevation myocardial infarction (STEMI) undergoing primary PCI",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F5174519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F141793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As with all anticoagulants, bleeding is the major adverse effect of bivalirudin. Hemorrhage may occur at virtually any site. Risk is dependent on multiple variables, including the intensity of anticoagulation, concurrent use of a glycoprotein IIb/IIIa inhibitor, and patient susceptibility. Additional adverse effects are often related to idiosyncratic reactions, and the frequency is difficult to estimate. Adverse reactions reported were generally less than those seen with heparin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (&le;12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Pain (&le;15%), headache (&le;12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (&le;15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Minor hemorrhage (REPLACE-2 study: Protocol defined: 14%, compared to 26% with heparin; TIMI defined: 1%, compared to 3% with heparin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain (9% to 42%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypertension (6%), bradycardia (5%), angina (&le;5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (7%), anxiety (6%), fever (5%), nervousness (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (&le;6%), dyspepsia (5%), abdominal pain (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary retention (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Major hemorrhage (Protocol defined: 2% to 4%, compared to 4% to 9% with heparin; REPLACE-2 Study: TIMI defined: 0.6%, compared to 0.9% with heparin), transfusion required (1% to 2%, compared to 2% to 6% with heparin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site pain (&le;8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Pelvic pain (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Allergic reaction (including anaphylaxis), cerebral ischemia, confusion, facial paralysis, fatal bleeding, infection, intracranial bleeding, pulmonary edema, renal failure, retroperitoneal bleeding, syncope, thrombocytopenia, thrombus formation (during PCI, including intracoronary brachytherapy), ventricular fibrillation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F141763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to bivalirudin or any component of the formulation; active major bleeding",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Major blood clotting disorders; acute gastric or duodenal ulcer; cerebral hemorrhage; severe cerebro-spinal trauma; bacterial endocarditis; severe uncontrolled hypertension; diabetic or hemorrhagic retinopathy; proximal use of spinal/epidural anesthesia",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F141748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding: The most common complication is bleeding. Certain patients are at increased risk of bleeding; risk factors include bacterial endocarditis; congenital or acquired bleeding disorders; recent puncture of large vessels or organ biopsy; recent CVA, stroke, intracerebral surgery, or other neuraxial procedure; severe uncontrolled hypertension; renal impairment; recent major surgery; recent major bleeding (intracranial, GI, intraocular, or pulmonary). Monitor for signs and symptoms of bleeding.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombus formation: Increased risk of thrombus formation (some fatal) has been reported with use in gamma brachytherapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Angina/ACS: Safety and efficacy have not been established in patients with unstable angina or acute coronary syndromes who are not undergoing PTCA or PCI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; dosage reduction required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intramuscular administration: Not for intramuscular (I.M.) use.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F141752\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: May enhance the anticoagulant effect of other Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Apixaban: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Anticoagulants may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Anticoagulants may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Anticoagulants. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Anticoagulants may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Anticoagulants may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of anticoagulants with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the adverse/toxic effect of Anticoagulants. Specifically, the antiplatelet effects of these agents may lead to an increased risk of bleeding with the combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Anticoagulants may enhance the anticoagulant effect of Rivaroxaban.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: May enhance the anticoagulant effect of Anticoagulants. Management: See full drug monograph for guidelines for the use of alteplase for acute ischemic stroke during treatment with oral anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Anticoagulants may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse effects may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the anticoagulant effect of Anticoagulants. Vitamin E may also increase the overall risk for bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F141754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F141766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies. Bivalirudin is used in conjunction with aspirin, which may lead to maternal or fetal adverse effects, especially during the third trimester. Use of parenteral direct thrombin inhibitors in pregnancy should be limited to those women who have severe allergic reactions to heparin, including heparin-induced thrombocytopenia, and who cannot receive danaparoid (Guyatt, 2012).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F141786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16248962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if bivalirudin is excreted in breast milk. The manufacturer recommends that caution be exercised when administering bivalirudin to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Angiomax Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (1): $957.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F141756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Depends upon indication for use of bivalirudin: ACT or aPTT",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F141767\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Angiomax (AR, AU, CN, IL, NZ);",
"     </li>",
"     <li>",
"      Angiox (AT, BE, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HN, IE, IT, MT, NL, NO, PL, PT, RU, SE, SK, TR);",
"     </li>",
"     <li>",
"      Bivaflo (IN);",
"     </li>",
"     <li>",
"      Bivasave (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F141747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bivalirudin acts as a specific and reversible direct thrombin inhibitor; it binds to the catalytic and anionic exosite of both circulating and clot-bound thrombin. Catalytic binding site occupation functionally inhibits coagulant effects by preventing thrombin-mediated cleavage of fibrinogen to fibrin monomers, and activation of factors V, VIII, and XIII. Shows linear dose- and concentration-dependent prolongation of ACT, aPTT, PT, and TT.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F141762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Immediate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Coagulation times return to baseline ~1 hour following discontinuation of infusion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 0.2 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding, plasma: Does not bind other than thrombin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Blood proteases",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Normal renal function (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &ge;90 mL/minute): 25 minutes; Severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute): 57 minutes; Dialysis-dependent patients (off dialysis): 3.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (20%), proteolytic cleavage",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Allie DE, Lirtzman MD, Wyatt CH, et al, &ldquo;Bivalirudin as a Foundation Anticoagulant in Peripheral Vascular Disease: A Safe and Feasible Alternative for Renal and Iliac Interventions,\"",
"      <i>",
"       J Invasive Cardiol",
"      </i>",
"      , 2003, 15(6):334-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12777673/pubmed\" id=\"12777673\" target=\"_blank\">",
"        12777673",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anderson JL, Adams CD, Antman EM, et al, &ldquo;ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration With the American College of Emergency Physicians, The Society of Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2007, 116(7):e148-304.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/17679616/pubmed\" id=\"17679616\" target=\"_blank\">",
"        17679616",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, Anbe SC, Alpert JS, et al, &ldquo;ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2004, 110(5):588-636.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/15289388/pubmed\" id=\"15289388\" target=\"_blank\">",
"        15289388",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Antman EM, &ldquo;Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289:903-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12588276/pubmed\" id=\"12588276\" target=\"_blank\">",
"        12588276",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aggarwal A, Sobel BE, and Schneider DJ, &ldquo;Decreased Platelet Reactivity in Blood Anticoagulated With Bivalirudin or Enoxaparin Compared With Unfractionated Heparin: Implications for Coronary Intervention,&rdquo;",
"      <i>",
"       J Thromb Thrombolysis",
"      </i>",
"      , 2002, 13:161-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12355033/pubmed\" id=\"12355033\" target=\"_blank\">",
"        12355033",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bittl JA, Chaitman BR, Feit F, et al, &ldquo;Bivalirudin Versus Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina: Final Report Reanalysis of the Bivalirudin Angioplasty Study,&rdquo;",
"      <i>",
"       Am Heart J",
"      </i>",
"      , 2001, 142:952-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/11717596/pubmed\" id=\"11717596\" target=\"_blank\">",
"        11717596",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bittl JA, Strony J, Brinker JA, et al, &ldquo;Treatment With Bivalirudin (Hirulog) as Compared With Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina. Hirulog Angioplasty Study Investigators,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1995, 333(12):764-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/7643883/pubmed\" id=\"7643883\" target=\"_blank\">",
"        7643883",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dager WE, Dougherty JA, Nguyen PH, et al, &ldquo;Heparin-Induced Thrombocytopenia: Treatment Options and Special Considerations,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2007, 27(4):564-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/17381384/pubmed\" id=\"17381384\" target=\"_blank\">",
"        17381384",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dangas GD, Mehran R, Nikolsky E, et al, &ldquo;Effect of Switching Antithrombin Agents for Primary Angioplasty in Acute Myocardial Infarction: The HORIZONS-SWITCH Analysis,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2001, 57(23):2309-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/21636031/pubmed\" id=\"21636031\" target=\"_blank\">",
"        21636031",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davis Z, Anderson R, Short D, et al, &ldquo;Favorable Outcome With Bivalirudin Anticoagulation During Cardiopulmonary Bypass,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2003, 75(1):264-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12537226/pubmed\" id=\"12537226\" target=\"_blank\">",
"        12537226",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dyke CM, Aldea G, Koster A, et al, &ldquo;Off-Pump Coronary Artery Bypass With Bivalirudin for Patients With Heparin-Induced Thrombocytopenia or Antiplatelet Factor Four/Heparin Antibodies,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2007, 84(3):836-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/17720385/pubmed\" id=\"17720385\" target=\"_blank\">",
"        17720385",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dyke CM, Smedira NG, Koster A, et al, &ldquo;A Comparison of Bivalirudin to Heparin With Protamine Reversal in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: The EVOLUTION-ON Study,&rdquo;",
"      <i>",
"       J Thorac Cardiovasc Surg",
"      </i>",
"      , 2006, 131(3):533-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/16515902/pubmed\" id=\"16515902\" target=\"_blank\">",
"        16515902",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fuchs J and Cannon CP, &ldquo;Hirulog in the Treatment of Unstable Angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 Trial,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 1995, 92(4):727-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/7641350/pubmed\" id=\"7641350\" target=\"_blank\">",
"        7641350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guyatt GH, Akl EA, Crowther M, et al, &ldquo;Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):7-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/22315257/pubmed\" id=\"22315257\" target=\"_blank\">",
"        22315257",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jneid H, Anderson JL, Wright RS, et al, &ldquo;2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 126(7):875-910.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/22800849/pubmed\" id=\"22800849\" target=\"_blank\">",
"        22800849",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kiser TH and Fish DN, &ldquo;Evaluation of Bivalirudin Treatment for Heparin-Induced Thrombocytopenia in Critically Ill Patients With Hepatic and/or Renal Dysfunction,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2006, 26(4):452-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/16553502/pubmed\" id=\"16553502\" target=\"_blank\">",
"        16553502",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kiser TH, Burch JC, Klem PM, et al, &ldquo;Safety, Efficacy, and Dosing Requirements of Bivalirudin in Patients With Heparin-induced Thrombocytopenia,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2008, 28(9):1115-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/18752382/pubmed\" id=\"18752382\" target=\"_blank\">",
"        18752382",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koster A, Chew D, Grundel M, et al, &ldquo;An Assessment of Different Filter Systems for Extracorporeal Elimination of Bivalirudin: An",
"      <i>",
"       In Vitro",
"      </i>",
"      Study,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2003, 96(5):1316-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12707125/pubmed\" id=\"12707125\" target=\"_blank\">",
"        12707125",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koster A, Chew D, Grundel M, et al, &ldquo;Bivalirudin Monitored With the Ecarin Clotting Time for Anticoagulation During Cardiopulmonary Bypass,&rdquo;",
"      <i>",
"       Anesth Analg",
"      </i>",
"      , 2003, 96(2): 383-6.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koster A, Dyke CM, Aldea G, et al, &ldquo;Bivalirudin During Cardiopulmonary Bypass in Patients With Previous or Acute Heparin-Induced Thrombocytopenia and Heparin Antibodies: Results of the CHOOSE-ON Trial,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2007, 83(2):572-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/17257990/pubmed\" id=\"17257990\" target=\"_blank\">",
"        17257990",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Koster A, Spiess B, Chew DP, et al. &ldquo;Effectiveness of Bivalirudin as a Replacement for Heparin During Cardiopulmonary Bypass in Patients Undergoing Coronary Artery Bypass Grafting,&rdquo;",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 2004, 93(3):356-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/14759391/pubmed\" id=\"14759391\" target=\"_blank\">",
"        14759391",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kushner FG, Hand M, Smith SC, et al, &ldquo;2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2009, 54(23):2205-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/19942100/pubmed\" id=\"19942100\" target=\"_blank\">",
"        19942100",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levine GN, Bates ER, Blankenship JC, et al, &ldquo;2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2011, 124(23):e574-651.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/22064601/pubmed\" id=\"22064601\" target=\"_blank\">",
"        22064601",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lincoff AM, Bittl JA, Harrington RA, et al, &ldquo;Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention. REPLACE-2 Randomized Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(7):853-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12588269/pubmed\" id=\"12588269\" target=\"_blank\">",
"        12588269",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lincoff AM, Kleiman NS, Kereiakes DJ, et al, &ldquo;Long-Term Efficacy of Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization: REPLACE-2 Randomized Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2004, 292(6):696-703.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/15304466/pubmed\" id=\"15304466\" target=\"_blank\">",
"        15304466",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lincoff AM, Kleiman NS, Kottke-Marchant K, et al, &ldquo;Bivalirudin With Planned or Provisional Abciximab Versus Low-Dose Heparin and Abciximab During Percutaneous Coronary Revascularization: Results of the Comparison of Abciximab Complications With Hirulog for Ischemic Events Trial (CACHET),&rdquo;",
"      <i>",
"       Am Heart J",
"      </i>",
"      , 2002, 143(5):847-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12040347/pubmed\" id=\"12040347\" target=\"_blank\">",
"        12040347",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Linkins L, Dans AL, Moores LK, et al, &ldquo;Treatment and Prevention of Heparin-Induced Thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2012, 141(2 Suppl):e495-530.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/22315270/pubmed\" id=\"22315270\" target=\"_blank\">",
"        22315270",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Merry AF, Raudkivi PJ, Middleton NG, et al, &ldquo;Bivalirudin Versus Heparin and Protamine in Off-Pump Coronary Artery Bypass Surgery,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2004, 77:925-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/14992900/pubmed\" id=\"14992900\" target=\"_blank\">",
"        14992900",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neuhaus KL, Molhoek GP, Zeymer U, et al, &ldquo;Recombinant Hirudin (Lepirudin) for the Improvement of Thrombolysis With Streptokinase in Patients With Acute Myocardial Infarction: Results of the HIT-4 Trial,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 1999, 34(4):966-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/10520777/pubmed\" id=\"10520777\" target=\"_blank\">",
"        10520777",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      O'Gara PT, Kushner FG, Ascheim DD, et al, \"2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2012, 127(4):e362-425.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/3247304/pubmed\" id=\"3247304\" target=\"_blank\">",
"        3247304",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robson R, &ldquo;The Use of Bivalirudin in Patients With Renal Impairment,&rdquo;",
"      <i>",
"       J Invasive Cardiol",
"      </i>",
"      , 2000, 12:33F-36F.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/11156732/pubmed\" id=\"11156732\" target=\"_blank\">",
"        11156732",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shammas NW, Lemke JH, Dippel EJ, et al, &ldquo;Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience,&rdquo;",
"      <i>",
"       J Invasive Cardiol",
"      </i>",
"      , 2003, 15(7):401-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12840239/pubmed\" id=\"12840239\" target=\"_blank\">",
"        12840239",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Smedira NG, Dyke CM, Koster A, et al, &ldquo;Anticoagulation With Bivalirudin For Off-Pump Coronary Artery Bypass Grafting: The Results Of The EVOLUTION-OFF Study,&rdquo;",
"      <i>",
"       J Thorac Cardiovasc Surg",
"      </i>",
"      , 2006, 131(3):686-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/16515924/pubmed\" id=\"16515924\" target=\"_blank\">",
"        16515924",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stone GW, McLaurin BT, Cox DA, et al, &ldquo;Bivalirudin for Patients With Acute Coronary Syndromes,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 355(21):2203-16.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/17124018/pubmed\" id=\"17124018\" target=\"_blank\">",
"        17124018",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stone GW, Witzenbichler B, Guagliumi G, et al, &ldquo;Bivalirudin During Primary PCI in Acute Myocardial Infarction,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2008, 358(21):2218-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/18499566/pubmed\" id=\"18499566\" target=\"_blank\">",
"        18499566",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tsu LV and Dager WE, &ldquo;Bivalirudin Dosing Adjustments for Reduced Renal Function With or Without Hemodialysis in the Management of Heparin-Induced Thrombocytopenia,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2011, 45(10):1185-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/21881032/pubmed\" id=\"21881032\" target=\"_blank\">",
"        21881032",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vasquez JC, Vichiendilokkul A, Mahmood S, et al, &ldquo;Anticoagulation With Bivalirudin During Cardiopulmonary Bypass in Cardiac Surgery,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2002, 74(6):2177-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?17/48/18184/abstract-text/12643418/pubmed\" id=\"12643418\" target=\"_blank\">",
"        12643418",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8792 Version 50.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-1E1E8CC54B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18184=[""].join("\n");
var outline_f17_48_18184=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141778\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141779\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141795\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141781\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141782\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141783\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141784\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141758\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141744\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141760\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471292\">",
"      Usual Infusion Concentrations: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141802\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141759\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5631572\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5174519\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141793\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141763\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141748\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298872\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141752\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141754\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141766\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141786\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16248962\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323020\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141756\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141767\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141747\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F141762\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8792\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8792|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/23/38259?source=related_link\">",
"      Bivalirudin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_48_18185="Management of food allergy: Avoidance";
var content_f17_48_18185=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of food allergy: Avoidance",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18185/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18185/contributors\">",
"     Scott H Sicherer, MD, FAAAAI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18185/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18185/contributors\">",
"     Robert A Wood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/48/18185/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/48/18185/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/48/18185/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary therapeutic strategy in the management of food allergy is avoidance of the culprit allergen. Complete avoidance is prescribed for IgE-mediated food allergies as well as food-protein enterocolitis in infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=see_link\">",
"     \"Food protein-induced proctitis/colitis and enteropathy of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Successful allergen avoidance is straightforward in theory; however in reality, avoidance requires extensive patient education. Clinicians should know how to instruct patients to read labels on packaged foods, prepare safe meals at home, and avoid food allergens in restaurant meals. Unintended exposure through cross-contact of foods in a variety of settings must be avoided. Food ingredients may be components of non-food items, such as medications and vaccines. They may also be incorporated into substances that are inadvertently ingested, such as cosmetics and children's crafts. Lastly, exposure to allergen-containing saliva may occur during kissing or sharing of utensils. This topic review will present each of these issues individually.",
"   </p>",
"   <p>",
"    The management of food allergy in daycare, schools, and camp settings is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3705?source=see_link\">",
"     \"Food allergy in schools and camps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with food allergy are typically instructed to practice strict avoidance. However, most patients attempting to eliminate a certain food from the diet will not be entirely successful, despite best efforts [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Thus, patients must be prepared to treat an unexpected reaction at all times and in any setting. A validated food allergy educational curriculum that describes specific food allergy disorders and addresses issues related to food allergen avoidance and use of self-injectable epinephrine is available for free at the",
"    <a class=\"external\" href=\"file://www.cofargroup.org/\">",
"     Food Allergy Educational Program of the Consortium of Food Allergy Research",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     How strict must avoidance be?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strict avoidance is recommended for most patients with food allergy. However, thresholds of clinical reactivity vary dramatically among allergic individuals and can also vary depending upon how the food is processed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=see_link\">",
"     \"Food allergens: Overview of clinical features and cross-reactivity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/42/43689?source=see_link\">",
"     \"Pathogenesis of food allergy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23433?source=see_link\">",
"     \"Molecular features of food allergens\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Important observations about avoidance include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Studies indicate that less than a milligram of milk, egg, or peanut, can induce symptoms in some highly sensitive individuals, while others may not experience a reaction until more than 10 grams have been ingested [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/4-7\">",
"       4-7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Clinical experience and observational studies show that some individuals with egg or milk allergy tolerate these foods in low amounts and as minor ingredients baked into products, such as cakes or cookies. In one series, 75 percent of children with milk allergy tolerated extensively heated milk in baked goods (muffins) and waffles [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/8\">",
"       8",
"      </a>",
"      ]. Similar results were found in a study of children with egg allergy who ingested extensively heated egg products [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/9\">",
"       9",
"      </a>",
"      ]. However, the consumer cannot determine the amount of allergen in a commercially-prepared food and the quantity may vary among batches, such that the food might be tolerated on one occasion and not another. Patients must be aware of these variables. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=see_link&amp;anchor=H6#H6\">",
"       \"Milk allergy: Management\", section on 'Dietary recommendations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13223?source=see_link&amp;anchor=H5#H5\">",
"       \"Egg allergy: Management\", section on 'Dietary recommendations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Certain types of mild allergy may not require strict avoidance, such as the pollen-food related syndrome or oral allergy syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=see_link&amp;anchor=H17#H17\">",
"       \"Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)\", section on 'Food avoidance'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, clinician experience and discretion is needed to tailor avoidance recommendations to the patient's specific situation and degree of sensitivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Skin contact and inhalation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food-allergic reactions generally occur following ingestion. Other routes of exposure, such as skin exposure or inhalation, are unlikely to cause reactions in most food-allergic people. Even in the most highly sensitive individuals, these types of exposure appear to cause very limited reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The most likely explanation for reactions that appear to occur in the absence of ingestion is inadvertent contact with the food and subsequent transfer of allergen from the hands to the mouth or other mucosal tissues.",
"   </p>",
"   <p>",
"    A small number of studies directly investigated the effects of non-ingestion exposures, with reassuring results:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study applied a gram of peanut butter for 15 minutes to the skin of 281 children who were skin prick test positive to peanut [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/13\">",
"       13",
"      </a>",
"      ]. The challenge was considered positive if one or more wheals (urticaria) were present when the peanut butter was removed, and 41 percent of tests were positive. No child experienced a systemic reaction. A subset of children with either positive or negative contact tests then underwent blinded, placebo controlled, oral challenges. In the contact-positive group, 82 percent of children reacted to ingesting peanut, while in the contact-negative group, 50 percent reacted. Thus, contact urticaria to peanut is not uncommon among peanut-allergic children and may be more likely in highly reactive children; however, no systemic reactions occurred during the 15 minute skin exposure.",
"     </li>",
"     <li>",
"      In another double-blind, placebo-controlled study, 30 children with histories of severe reactions to peanut ingestion were challenged by close",
"      <span class=\"nowrap\">",
"       proximity/smelling",
"      </span>",
"      peanut butter [",
"      <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/11\">",
"       11",
"      </a>",
"      ]. A six inch square area of peanut butter hidden with sheer gauze was placed 12 inches from the children's faces for 10 minutes. No child experienced symptoms from",
"      <span class=\"nowrap\">",
"       proximity/smelling",
"      </span>",
"      of peanut butter, although one experienced throat symptoms during exposure to placebo (presumably from anxiety).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There is a distinction between smelling a food and inhaling an aerosolized food. Simply smelling a non-cooking food can result from contact between the nasal mucosa and airborne volatile organic compounds (VOCs) given off continuously by foods [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/14\">",
"     14",
"    </a>",
"    ]. In contrast, inhalation of aerosolized food implies actual contact between food matter and the respiratory mucosa (nasal or pulmonary). Aerosolization of food can occur as a result of cooking or processing (eg, boiling, frying, grating, shredding, grinding).",
"   </p>",
"   <p>",
"    During aerosolization, actual food matter, including proteins, may become airborne. This is critical, because all identified food allergens are proteins, and these proteins are the necessary inciting agents of allergic reactions. Inhalation contact with aerosolized food has been shown to be capable of inducing asthmatic or respiratory reactions in highly sensitive individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/12,15\">",
"     12,15",
"    </a>",
"    ]. To avoid respiratory reactions, highly sensitive individuals should avoid situations in which aerosolized food could be inhaled, including proximity to steam and vapors from cooking, or proximity to an activity involving chopping, grinding, or vigorously manipulating the culprit food.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22789097\">",
"    <span class=\"h2\">",
"     Maternal dietary avoidance of allergens for infants with proven food allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food allergens ingested by the mother can be detected in breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. A study in which 23 women ingested 50 g of dry roasted peanut found that peanut protein was detectable in 11 (48 percent) participants, with a median peak protein concentration of 200",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/16\">",
"     16",
"    </a>",
"    ]. There are case reports and case series indicating that allergic reactions, including anaphylaxis, can occur in the infant from transfer of maternally ingested allergen through breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/17-20\">",
"     17-20",
"    </a>",
"    ]. There is also evidence that infants may have chronic atopic dermatitis or gastrointestinal symptoms (vomiting, diarrhea, failure to thrive, proctocolitis) triggered by food allergens in breast milk [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/17,21,22\">",
"     17,21,22",
"    </a>",
"    ]. Food protein-induced enterocolitis syndrome triggered by allergen in breast milk is also possible, although rare [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/12/2250?source=see_link\">",
"     \"Food protein-induced enterocolitis syndrome (FPIES)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When a breastfed infant is diagnosed with an allergy to a specific food, the infant must avoid direct ingestion of the allergen. Options regarding the maternal diet include strict avoidance, reduced ingestion, no avoidance, or, for milk and egg, ingestion of only extensively heated forms (eg, bakery goods) that appear to have reduced allergenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/9,25\">",
"     9,25",
"    </a>",
"    ]. An alternative option is the cessation of breast feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/21\">",
"     21",
"    </a>",
"    ]. There are no controlled trials upon which to base recommendations about maternal avoidance, and strict avoidance could be recommended in all circumstances.",
"   </p>",
"   <p>",
"    Maternal dietary allergen avoidance while breastfeeding an infant with food allergy has been suggested by a number of expert panels, primarily ones that address milk allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/26-30\">",
"     26-30",
"    </a>",
"    ]. However, arguments against strict maternal avoidance, if there are no apparent ill effects on the infant during maternal consumption, include improved",
"    <span class=\"nowrap\">",
"     maternal/infant",
"    </span>",
"    nutrition and quality of life. Additionally, there is a lack of data on whether allergens in breast milk are tolerizing or sensitizing for the infant. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20119?source=see_link\">",
"     \"Primary prevention of allergic disease: Maternal avoidance diets in pregnancy and lactation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We generally recommend strict maternal dietary avoidance if the infant had an acute reaction to an allergen in breast milk, a severe anaphylactic reaction to an allergen the infant ingested directly, chronic symptoms attributable to the food despite a low maternal intake of the trigger, or a reaction to a food that often triggers severe reactions and is generally eaten by the mother in larger quantities during meals (eg, peanut, nuts, fish, shellfish).",
"   </p>",
"   <p>",
"    We discuss the option of reducing maternal intake of the allergen (at or below amounts ingested prior to diagnosis) or using baked forms of milk or egg when the infant had no chronic symptoms while breastfeeding prior to a diagnosis of food allergy or when maternal dietary allergen reduction resolves mild chronic symptoms. In one study of infants with cow&rsquo;s milk allergy, the median dose of milk ingested by the mother that elicited symptoms, primarily flaring of eczema, in the breastfed infant was 700 mL [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When mothers follow avoidance diets, nutritional issues should be addressed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7993?source=see_link\">",
"     \"Nutritional issues in food allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SKILLS FOR DAILY LIVING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients and parents must become proficient in label reading, meal preparation, and if the patient eats in restaurants, communicating their needs to the staff. Consultation with a registered dietitian can be helpful in developing a plan for food allergen avoidance and preventing dietary deficiencies, especially in children with multiple food allergies [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Food labeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laws regarding what a manufacturer is required to present on an ingredient statement of a prepared food varies by country [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/33\">",
"     33",
"    </a>",
"    ]. Concerns for a food allergic consumer include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disclosure of all ingredients",
"     </li>",
"     <li>",
"      Disclosure of potential cross-contact of allergen with the final food product",
"     </li>",
"     <li>",
"      Manufacturing procedures that provide consistent ingredients (eg, no inadvertent inclusion of an undisclosed allergen)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Legislation in the United States",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, the Food Allergen Labeling and Consumer Protection Act (FALCPA) of 2004 is a law requiring that the eight major allergens or allergenic food groups &mdash; milk, egg, fish, crustacean shellfish, tree nuts, wheat, peanut, and soy &mdash; be declared on ingredient labels using these plain English words. These allergens must be listed if they are present as an ingredient, in any amount. The plain English words used to identify the foods may be placed within the ingredient list or as a separate \"contains\" statement. The law also requires that the specific type of allergen within a category be named, such as hazelnut or walnut, in addition to \"tree nuts.\"",
"   </p>",
"   <p>",
"    FALCPA applies to foods manufactured in the United States, as well as packaged foods that are imported for sale and subject to FDA regulation. FALCPA applies to all types of packaged foods except for meat, egg, and poultry products, and raw agricultural foods, such as fruits and vegetables in their natural state.",
"   </p>",
"   <p>",
"    Previously, foods could be labeled only with scientific or nonspecific terms (eg, casein or \"natural flavor\" for milk). Patients had to be aware of all the terms that could be used to refer to a common food (",
"    <a class=\"graphic graphic_table graphicRef63271 \" href=\"UTD.htm?37/5/37980\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef53488 \" href=\"UTD.htm?7/56/8076\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef75071 \" href=\"UTD.htm?31/41/32412\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef70268 \" href=\"UTD.htm?28/25/29084\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef77407 \" href=\"UTD.htm?14/44/15052\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56449 \" href=\"UTD.htm?0/13/221\">",
"     table 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef67907 \" href=\"UTD.htm?34/43/35516\">",
"     table 7",
"    </a>",
"    ). The law still allows the use of such terms, although plain English must also be present. FALCPA",
"    <strong>",
"     only",
"    </strong>",
"    applies to the eight major allergens listed here. Other allergens, such as garlic or sesame, may still be listed using ambiguous terms, such as \"spice.\" In some cases where ambiguous terms remain, a consumer may need to call the manufacturer to clarify ingredients. In regards to soy, terms such as soybean, soy, and soya are considered interchangeable. For seafood, FALCPA requires the identification of finned fish and crustacean shellfish (eg, lobster, shrimp, crab), although non-crustaceans, such as squid or mollusks (eg, clams, mussels, oysters) do not have to be identified. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=see_link\">",
"     \"Seafood allergies: Fish and shellfish\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The FALCPA legislation does not define a safe threshold of included allergen and several food ingredients may now be included on labels that did not previously disclose them. Processing aids, such as soy lecithin, a fatty derivative of soy which contains a very small amount of soy protein, may now appear as \"soy.\" (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Medications and asthma inhalers'",
"    </a>",
"    below.) The law acknowledges that certain forms of highly processed oils may not contain any appreciable protein, for example, soy oil. FALCPA is likely to be revised by allowed petition. Updates are available from the Center for Food Safety and Applied Nutrition, a branch of the Food and Drug Administration [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon studies of consumer interpretation of labels and resultant behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/35\">",
"     35",
"    </a>",
"    ], this legislation should reduce the number of allergic reactions caused by consumer misunderstanding of labeling terms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Legislation in other countries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other countries are addressing issues of food labeling as well. The European Union enacted legislation in 2005 requiring that the following common allergens must be listed if present in",
"    <strong>",
"     any",
"    </strong>",
"    amount: milk, egg, fish, crustacean shellfish, peanuts, soybeans, tree nuts, cereals containing gluten (wheat, rye, barley, oats, spelt, and their hybridized strains), celery, mustard, and sesame seeds [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/33,36\">",
"     33,36",
"    </a>",
"    ]. In addition, any other ingredients that comprise 5 percent or more of the food must be listed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Advisory labeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain phrases are used by the food industry when a particular allergen is not an intended ingredient of the food, but rather may contact or become a part of the food despite accepted manufacturing processes. Various terms are used, including: \"may contain,\" \"processed in a facility with,\" \"manufactured on shared equipment with,\" and others. These terms are applied at the discretion of the manufacturer. Such labeling is common; an extensive audit of 20,241 supermarket products found that 17 percent had advisory labeling [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advisory labeling can be both beneficial and detrimental to food-allergic individuals. The risk of allergen exposure is likely reduced, although if the terms are applied too broadly to food products that pose little risk, allergic consumers may chose to ignore the warnings in order to expand their dietary options [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. We advise patients to avoid foods that include the culprit allergen in an advisory statement, because it is impossible for the consumer to determine the actual risk, and serious reactions from cross-contact have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study of over 600 consumers who shop for persons with food allergies showed that significantly fewer were avoiding products with advisory labels in 2006 than in 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/38\">",
"     38",
"    </a>",
"    ]. Shoppers judged risk based upon label terminology. As an example, they were more likely to purchase products labeled \"Made in a facility that processes peanut\" than those labeled \"May contain peanut\" when shopping for a peanut-allergic patient. However, assays of a sample of 179 products with advisory labeling for peanut disclosed that 7 percent of the products contained detectable peanut protein regardless of how the warning was stated. Thus, consumers are increasingly taking risks and falsely assuming that the label terminology reflects the risk level.",
"   </p>",
"   <p>",
"    Another study examined products with milk advisory labeling [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/41\">",
"     41",
"    </a>",
"    ]. Detectable milk was found in 34 of 81 (42 percent) of these products, a much higher frequency than similar studies of peanut. The study included 18 dark chocolate products, 78 percent of which had detectable milk protein. Estimates of the doses of milk that might be ingested in a normal serving size of these milk-contaminated products ranged from 0.027 to 620 mg of milk.",
"   </p>",
"   <p>",
"    In a study of a selection of 401 products from among types having a higher rate of advisory labeling (baking and pancake mixes, chocolate and nonchocolate candies, cookies, salty snacks, cold cereals, and pastas), 3 of 26 products labeled as using &ldquo;Good Manufacturing Practices&rdquo; had detectable levels of unintended allergens (all from one supermarket chain) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/42\">",
"     42",
"    </a>",
"    ]. Overall, contamination with an allergenic food (milk, egg, or peanut) was seen in 5.3 percent of products with advisory statements and in 1.9 percent of similar products without this labeling. Contaminated products were more commonly from small (5.1 percent) rather than large (0.75 percent) companies.",
"   </p>",
"   <p>",
"    Certain groups of food allergic individuals are less likely to heed advisory labeling, specifically teenagers and young adults. In a study of 174 adolescents and young adults with food allergy, 42 percent were willing to eat foods labeled \"may contain\" an allergen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Alcoholic beverages",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in the United States should be aware that alcoholic beverages may also contain allergens, including unexpected ones such as eggs, cow's milk, and seafood (used as clarifying agents). FALCPA does not cover alcoholic beverages, although the federal agency that oversees labeling of alcohol has stated an intention to apply similar rules in the near future. For persons in the European Union, the European Food Safety Authority has exempted fermentation substrates and their products, including bacterial cultures and enzymes, from labeling laws [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/33\">",
"     33",
"    </a>",
"    ]. At least two small studies concluded that the use of allergenic food-stuffs as clarifying agents in wine did not result in clinically significant reactions in patients allergic to the food in question, even when prick skin tests to the wine were positive [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Home meal preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some families avoid bringing food into the home to which one member is allergic, while others keep the food in the house and avoid cross-contact. Principles of avoidance of cross-contact must be reviewed carefully with",
"    <span class=\"nowrap\">",
"     patients/families.",
"    </span>",
"    Utensils, cookware, glassware, storage containers, and other food preparation materials in contact with an allergen should not be used to prepare or serve \"safe\" meals, unless thoroughly cleaned first. Alternatively, the safe meal can be prepared first as a matter of routine before other food. Additional tips include keeping food containers covered to prevent spill-contamination and designating specific containers of food for use by the allergic person only.",
"   </p>",
"   <p>",
"    Vigilance for cross-contact must be practiced by everyone in the family, including other small children. For example, a knife used to prepare peanut butter and jelly by a non-allergic child could introduce peanut allergen into otherwise safe jelly and subsequently cause a reaction in a peanut-allergic sibling eating the jelly [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cleaning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although only investigated for peanut butter, cleaning tabletops with several standard cleansers was sufficient for removal of peanut allergen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/47\">",
"     47",
"    </a>",
"    ]. Household cleaners (with the exception of dishwashing liquid) and commercial wipes effectively removed peanut allergen from table tops. Both liquid or bar soap, but not alcohol-based antibacterial gels, removed peanut allergen from adults' hands. This study is reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3705?source=see_link\">",
"     \"Food allergy in schools and camps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Restaurant meals",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study of persons with peanut and tree nut allergies revealed that certain restaurants or food services were high risk: ice cream parlors, bakeries, and Asian restaurants [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/48\">",
"     48",
"    </a>",
"    ]. These types of restaurants frequently use",
"    <span class=\"nowrap\">",
"     peanut/nut",
"    </span>",
"    ingredients and are prone to cross-contact. Similarly, persons with a seafood allergy would likely have more difficulty obtaining a safe meal from a restaurant that specializes in seafood. Buffet services should be avoided due to the risk of cross-contact. Additional problems identified are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef76289 \" href=\"UTD.htm?14/38/14955\">",
"     table 8",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    One study administered telephone questionnaires to 100 individuals (including managers, servers, chefs, and other personnel) employed in various restaurants and food establishments in the New York City area [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/49\">",
"     49",
"    </a>",
"    ]. Five true or false questions about food allergy were presented, and only 22 percent of respondents answered all five correctly. Despite this, approximately 50 percent of respondents felt \"very comfortable\" that they could provide a safe meal to a food-allergic customer. A British study found a similar disconnect between restaurant staff knowledge and comfort level in providing safe meals to those with food allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/50\">",
"     50",
"    </a>",
"    ]. Patients should not assume that restaurant personnel understand food allergy or know what steps must be taken to guarantee that a meal is safe.",
"   </p>",
"   <p>",
"    Consumers should identify that they have an allergy (not just distaste for the food) to those who are directly responsible for preparing the meal (ie, the cook, rather than the waitstaff). It is helpful to carry a supply of pre-printed cards with clear information about which foods cannot be eaten, and a reminder that cooking containers and serving utensils cannot be contaminated with the allergenic food. As an example, it may be necessary to prepare food in cleaned pans and glassware rather than to use shared grills or blenders. Deep fryers, in which oil is reused for frying different foods, should be avoided, as the oil easily becomes contaminated with protein from previously cooked foods. Ingredient lists on menus should not be trusted at face value, and the absence of allergens should be verified for any dish ordered. Detailed guidelines for restaurants are available through the",
"    <a class=\"external\" href=\"file://www.foodallergy.org/\">",
"     Food Allergy &amp; Anaphylaxis Network (FAAN)",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Airline travel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic reactions to peanut and tree nuts have been reported on commercial airliners [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/51-54\">",
"     51-54",
"    </a>",
"    ]. Studies of these events have relied upon self-reported reactions to ingestion, skin contact, and inhalation. The degree of risk is difficult to ascertain from these studies. However, travelers with food allergies should avoid eating potentially unsafe airline foods. Those traveling with young children may wish to clean tray tables and inspect seating areas for residual foods that might be ingested by toddlers. Some airlines may provide additional accommodations when requested in advance (eg, a flight where peanuts are not served).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     FOOD ALLERGENS IN NON-FOOD ITEMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consumers with food allergy should be instructed that non-food items may contain food ingredients, such as medications, vaccines, cosmetics, and craft supplies. Labeling laws do not apply to these products.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Vaccines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consumers and clinicians should be aware that vaccines can contain food allergens, including egg, chicken, cow&rsquo;s milk, and gelatin proteins. The evaluation and management of allergic reactions to vaccines is presented in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43097?source=see_link\">",
"     \"Allergic reactions to vaccines\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20967?source=see_link\">",
"     \"Influenza vaccination in individuals with egg allergy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Medications and asthma inhalers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over-the-counter and prescription medications in tablet and capsule form, some inhaled medications for asthma, and some brands of injectable glucocorticoids can also contain food allergens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Lactose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactose is a milk sugar derived from milk that is used in many dry powder asthma inhalers, some brands of oral and injectable glucocorticoids, and a few oral medications that are commonly used in atopic patients. Pharmaceutical-grade lactose is considered to contain very little to no milk protein, on the order of a few parts per million. However, possible reactions in children with severe milk allergy have been reported and small amounts of milk proteins have been detected in various DPI devices [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/55\">",
"     55",
"    </a>",
"    ] and injectable methyl-prednisolone (Solu-Medrol 40 mg) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/56\">",
"     56",
"    </a>",
"    ]. We prefer lactose-free preparations or metered dose inhalers (which use liquid medications and propellants) for patients with asthma and milk allergy. We also avoid, when practical, other lactose-containing medications (eg, Prevacid Solutab, chewable Zyrtec, Singulair 10 mg) in highly milk-allergic patients for the same reason.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Soy lecithin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain inhalers and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    contain soy lecithin, which is the fatty derivative of soy. Soy lecithin contains a trace amount of detectable soy protein [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The product insert on some of these medications indicates a contraindication for the use of products with soy lecithin if there is an allergy to soybean or peanut. However, the degree of risk for use of soy-lecithin containing medications in persons with peanut or soy allergy has not been systematically evaluated. Considering the small amount of protein present, the risk of a reaction from these medications seems very low [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/35,59\">",
"     35,59",
"    </a>",
"    ]. In addition, over 90 percent of peanut-allergic individuals tolerate soy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/60\">",
"     60",
"    </a>",
"    ]. Thus, although the use of these medications in highly-sensitive soy or peanut allergic patients is generally avoided, there may be situations in which exceptions are appropriate, following a discussion of risks and benefits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Casein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Casein, a cow's milk protein, has been used as an anti-stick agent on latex gloves [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Egg lysozyme",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lysozyme, an enzyme found in egg white, is used in pharmaceutical products. Severe acute hypersensitivity reactions to lysozyme have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Cosmetics and crafts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various cosmetics may contain a variety of food-derived ingredients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Milk, nut oils, wheat, and soy may be used in cosmetics. Children's craft items such as modeling dough may contain wheat. Sometimes egg white is used to smooth finger paints.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     INTERPERSONAL CONTACT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A source of unintended and unexpected allergen exposure is through saliva or other bodily fluids from an individual who recently ingested an allergen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Saliva",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food allergic individuals should be warned that exposure may occur through kissing, as well as sharing straws, glasses, or utensils. Kissing, in particular passionate kissing, is a relatively common route of exposure. Of 379 allergy patients in the US with",
"    <span class=\"nowrap\">",
"     peanut/tree",
"    </span>",
"    <span class=\"nowrap\">",
"     nut/legume",
"    </span>",
"    or seed allergy, over 5 percent reported reactions from kissing [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/65\">",
"     65",
"    </a>",
"    ]. Of 839 food allergy patients in Denmark, 16 percent reported reactions after kissing [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study was undertaken to determine the time course of peanut protein (a marker protein Ara h 1) in saliva after a meal of peanut butter, and possible methods for reducing levels [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/67\">",
"     67",
"    </a>",
"    ]. Detection of Ara h 1 in saliva was performed by a monoclonal-based ELISA (detection limit, 15 to 20",
"    <span class=\"nowrap\">",
"     ng/ml).",
"    </span>",
"    Most (87 percent) subjects with detectable peanut after a meal had undetectable levels by one hour with no interventions. None had detectable levels several hours later following a subsequent peanut-free lunch.",
"   </p>",
"   <p>",
"    In the same study, various immediate interventions following a peanut butter meal were assessed, including immediate brushing, prolonged rinsing, both, waiting an hour then brushing, or waiting 30 minutes then chewing gum [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/67\">",
"     67",
"    </a>",
"    ]. None of these interventions consistently resulted in undetectable levels, although levels were lower than might usually be expected to trigger a reaction (below 17 micrograms of peanut protein in 5 ml of saliva). The immediate interventions led to undetectable levels in only one in five subjects. However, methods which included a waiting period reduced salivary allergen to undetectable levels in 8 of 10 (wait-brush) and 8 of 9 (wait-gum) subjects. The studies were performed with peanut butter and results may vary with other allergens or forms of peanut. There is one case report of a mild reaction to peanut despite a two hour wait, brushing teeth, and chewing gum [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, allergen exposure through contact with saliva from another person who has recently ingested the food is possible. Waiting several hours and then eating other foods appears to be more reliable in reducing salivary allergen levels than attempts to cleanse the mouth immediately after allergen ingestion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Other bodily fluids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Food-allergic reactions from blood transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?17/48/18185/abstract/69\">",
"     69",
"    </a>",
"    ] or semen are theoretically possible, although not commonly observed. Possible explanations include the reduction of plasma fractions in blood prepared for transfusion, and likely avoidance by partners of large amounts of the allergen proximate to intimate contact.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=see_link\">",
"       \"Patient information: Food allergy treatment and avoidance (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Once a diagnosis of food allergy is made, education of patients (and families) about avoidance is a crucial therapeutic intervention. Strict avoidance is simple in theory and difficult in practice. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The vast majority of serious allergic reactions follow ingestion of food. Skin contact may cause local cutaneous symptoms and inhalation may cause rhinitis and asthmatic symptoms. Simply smelling food is not associated with allergic reactions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General considerations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Labeling laws vary by country. As of January 2006 in the United States, legislation requires declaration of eight \"major allergens\" in plain English: milk, egg, fish, shellfish, tree nuts, wheat, peanut and soy. However, all other ingredients may still be listed using ambiguous terms, such as \"natural flavor\" or \"spices.\" (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Food labeling'",
"      </a>",
"      above). Tables of terms used for these common allergens are provided (",
"      <a class=\"graphic graphic_table graphicRef63271 \" href=\"UTD.htm?37/5/37980\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef53488 \" href=\"UTD.htm?7/56/8076\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef75071 \" href=\"UTD.htm?31/41/32412\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef70268 \" href=\"UTD.htm?28/25/29084\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef77407 \" href=\"UTD.htm?14/44/15052\">",
"       table 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef56449 \" href=\"UTD.htm?0/13/221\">",
"       table 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef67907 \" href=\"UTD.htm?34/43/35516\">",
"       table 7",
"      </a>",
"      ). Similar laws are in effect for countries in the European Union.",
"     </li>",
"     <li>",
"      Preparation of allergen-free meals for a family where some members continue to eat the allergenic food requires education about cross-contact, safe storage, and cleaning procedures. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Skills for daily living'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obtaining safe restaurant meals requires a direct conversation between the consumer and the person preparing the meal. Patients need to report which foods they cannot eat and the need to avoid cross-contact with the allergen during preparation and serving. Cards pre-printed with the critical information can be handed to the cook to reinforce verbal instructions. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Restaurant meals'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medications, vaccines, cosmetics, and craft items are other unexpected sources of exposure. Asthma inhalers may contain trace amounts of soy or milk protein. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Food allergens in non-food items'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Allergic reactions may result from exposure to the saliva from another person who has recently ingested an allergenic food, through sharing utensils and intimate kissing. To lower salivary allergen levels, waiting several hours and eating other foods is more effective than immediate interventions like brushing teeth or chewing gum. Reactions resulting from other forms of intimate contact are rarely reported. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Interpersonal contact'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/1\">",
"      Yu JW, Kagan R, Verreault N, et al. Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol 2006; 118:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/2\">",
"      Boyano-Mart&iacute;nez T, Garc&iacute;a-Ara C, Pedrosa M, et al. Accidental allergic reactions in children allergic to cow's milk proteins. J Allergy Clin Immunol 2009; 123:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/3\">",
"      Sicherer SH, Vargas PA, Groetch ME, et al. Development and validation of educational materials for food allergy. J Pediatr 2012; 160:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/4\">",
"      Taylor SL, Hefle SL, Bindslev-Jensen C, et al. Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol 2002; 109:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/5\">",
"      Taylor SL, Hefle SL, Bindslev-Jensen C, et al. A consensus protocol for the determination of the threshold doses for allergenic foods: how much is too much? Clin Exp Allergy 2004; 34:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/6\">",
"      Sicherer SH, Morrow EH, Sampson HA. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis. J Allergy Clin Immunol 2000; 105:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/7\">",
"      Flinterman AE, Pasmans SG, Hoekstra MO, et al. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children. J Allergy Clin Immunol 2006; 117:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/8\">",
"      Nowak-Wegrzyn A, Bloom KA, Sicherer SH, et al. Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 2008; 122:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/9\">",
"      Lemon-Mul&eacute; H, Sampson HA, Sicherer SH, et al. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008; 122:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/10\">",
"      Ma S, Sicherer SH, Nowak-Wegrzyn A. A survey on the management of pollen-food allergy syndrome in allergy practices. J Allergy Clin Immunol 2003; 112:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/11\">",
"      Simonte SJ, Ma S, Mofidi S, Sicherer SH. Relevance of casual contact with peanut butter in children with peanut allergy. J Allergy Clin Immunol 2003; 112:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/12\">",
"      Roberts G, Golder N, Lack G. Bronchial challenges with aerosolized food in asthmatic, food-allergic children. Allergy 2002; 57:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/13\">",
"      Wainstein BK, Kashef S, Ziegler M, et al. Frequency and significance of immediate contact reactions to peanut in peanut-sensitive children. Clin Exp Allergy 2007; 37:839.",
"     </a>",
"    </li>",
"    <li>",
"     Young MC. Common beliefs about peanut allergies: Fact or fiction. Food Allergy News 2003; 12:1. The Food Allergy &amp; Anaphylaxis Network. Fairfax, VA.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/15\">",
"      Tonnel AB, Tillie-Leblond I, Botelho AD, et al. Severe acute asthma associated with raw meat cutting. Ann Allergy Asthma Immunol 2009; 102:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/16\">",
"      Vadas P, Wai Y, Burks W, Perelman B. Detection of peanut allergens in breast milk of lactating women. JAMA 2001; 285:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/17\">",
"      J&auml;rvinen KM, M&auml;kinen-Kiljunen S, Suomalainen H. Cow's milk challenge through human milk evokes immune responses in infants with cow's milk allergy. J Pediatr 1999; 135:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/18\">",
"      Lifschitz CH, Hawkins HK, Guerra C, Byrd N. Anaphylactic shock due to cow's milk protein hypersensitivity in a breast-fed infant. J Pediatr Gastroenterol Nutr 1988; 7:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/19\">",
"      Monti G, Marinaro L, Libanore V, et al. Anaphylaxis due to fish hypersensitivity in an exclusively breastfed infant. Acta Paediatr 2006; 95:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/20\">",
"      Des Roches A, Paradis L, Singer S, Seidman E. An allergic reaction to peanut in an exclusively breastfed infant. Allergy 2005; 60:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/21\">",
"      Isolauri E, Tahvanainen A, Peltola T, Arvola T. Breast-feeding of allergic infants. J Pediatr 1999; 134:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/22\">",
"      Lake AM. Food-induced eosinophilic proctocolitis. J Pediatr Gastroenterol Nutr 2000; 30 Suppl:S58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/23\">",
"      Monti G, Castagno E, Liguori SA, et al. Food protein-induced enterocolitis syndrome by cow's milk proteins passed through breast milk. J Allergy Clin Immunol 2011; 127:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/24\">",
"      Leonard SA, Nowak-Wgrzyn A. Food protein-induced enterocolitis syndrome: an update on natural history and review of management. Ann Allergy Asthma Immunol 2011; 107:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/25\">",
"      Kim JS, Nowak-Wgrzyn A, Sicherer SH, et al. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 2011; 128:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/26\">",
"      Fiocchi A, Brozek J, Sch&uuml;nemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol 2010; 21 Suppl 21:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/27\">",
"      Vandenplas Y, Koletzko S, Isolauri E, et al. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child 2007; 92:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/28\">",
"      Kemp AS, Hill DJ, Allen KJ, et al. Guidelines for the use of infant formulas to treat cows milk protein allergy: an Australian consensus panel opinion. Med J Aust 2008; 188:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/29\">",
"      American Academy of Pediatrics. Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 2000; 106:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/30\">",
"      H&oslash;st A, Koletzko B, Dreborg S, et al. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child 1999; 81:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/31\">",
"      Lack G. Clinical practice. Food allergy. N Engl J Med 2008; 359:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/32\">",
"      Ald&aacute;miz-Echevarr&iacute;a L, Bilbao A, Andrade F, et al. Fatty acid deficiency profile in children with food allergy managed with elimination diets. Acta Paediatr 2008; 97:1572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/33\">",
"      Taylor SL, Hefle SL. Food allergen labeling in the USA and Europe. Curr Opin Allergy Clin Immunol 2006; 6:186.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Food Safety and Applied Nutrition. www.cfsan.fda.gov (Accessed on February 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/35\">",
"      Simons E, Weiss CC, Furlong TJ, Sicherer SH. Impact of ingredient labeling practices on food allergic consumers. Ann Allergy Asthma Immunol 2005; 95:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/36\">",
"      Warner JO. European Food Labelling Legislation--a nightmare for food manufacturers and allergy sufferers alike. Pediatr Allergy Immunol 2005; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/37\">",
"      Pieretti MM, Chung D, Pacenza R, et al. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol 2009; 124:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/38\">",
"      Hefle SL, Furlong TJ, Niemann L, et al. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. J Allergy Clin Immunol 2007; 120:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/39\">",
"      Noimark L, Gardner J, Warner JO. Parents' attitudes when purchasing products for children with nut allergy: a UK perspective. Pediatr Allergy Immunol 2009; 20:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/40\">",
"      Jones RT, Squillace DL, Yunginger JW. Anaphylaxis in a milk-allergic child after ingestion of milk-contaminated kosher-pareve-labeled \"dairy-free\" dessert. Ann Allergy 1992; 68:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/41\">",
"      Crotty MP, Taylor SL. Risks associated with foods having advisory milk labeling. J Allergy Clin Immunol 2010; 125:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/42\">",
"      Ford LS, Taylor SL, Pacenza R, et al. Food allergen advisory labeling and product contamination with egg, milk, and peanut. J Allergy Clin Immunol 2010; 126:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/43\">",
"      Sampson MA, Mu&ntilde;oz-Furlong A, Sicherer SH. Risk-taking and coping strategies of adolescents and young adults with food allergy. J Allergy Clin Immunol 2006; 117:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/44\">",
"      Kirschner S, Belloni B, Kugler C, et al. Allergenicity of wine containing processing aids: a double-blind, placebo-controlled food challenge. J Investig Allergol Clin Immunol 2009; 19:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/45\">",
"      Rolland JM, Apostolou E, Deckert K, et al. Potential food allergens in wine: double-blind, placebo-controlled trial and basophil activation analysis. Nutrition 2006; 22:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/46\">",
"      Sicherer SH, Furlong TJ, Mu&ntilde;oz-Furlong A, et al. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001; 108:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/47\">",
"      Perry TT, Conover-Walker MK, Pom&eacute;s A, et al. Distribution of peanut allergen in the environment. J Allergy Clin Immunol 2004; 113:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/48\">",
"      Furlong TJ, DeSimone J, Sicherer SH. Peanut and tree nut allergic reactions in restaurants and other food establishments. J Allergy Clin Immunol 2001; 108:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/49\">",
"      Ahuja R, Sicherer SH. Food-allergy management from the perspective of restaurant and food establishment personnel. Ann Allergy Asthma Immunol 2007; 98:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/50\">",
"      Bailey S, Albardiaz R, Frew AJ, Smith H. Restaurant staff's knowledge of anaphylaxis and dietary care of people with allergies. Clin Exp Allergy 2011; 41:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/51\">",
"      Sicherer SH, Furlong TJ, DeSimone J, Sampson HA. Self-reported allergic reactions to peanut on commercial airliners. J Allergy Clin Immunol 1999; 104:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/52\">",
"      Comstock SS, DeMera R, Vega LC, et al. Allergic reactions to peanuts, tree nuts, and seeds aboard commercial airliners. Ann Allergy Asthma Immunol 2008; 101:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/53\">",
"      Greenhawt MJ, McMorris MS, Furlong TJ. Self-reported allergic reactions to peanut and tree nuts occurring on commercial airlines. J Allergy Clin Immunol 2009; 124:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/54\">",
"      Greenhawt M, MacGillivray F, Batty G, et al. International study of risk-mitigating factors and in-flight allergic reactions to peanut and tree nut. J Allergy Clin Immunol: In Practice 2013; 1:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/55\">",
"      Nowak-Wegrzyn A, Shapiro GG, Beyer K, et al. Contamination of dry powder inhalers for asthma with milk proteins containing lactose. J Allergy Clin Immunol 2004; 113:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/56\">",
"      Savvatianos S, Giavi S, Stefanaki E, et al. Cow's milk allergy as a cause of anaphylaxis to systemic corticosteroids. Allergy 2011; 66:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/57\">",
"      Gu X, Beardslee T, Zeece M, et al. Identification of IgE-binding proteins in soy lecithin. Int Arch Allergy Immunol 2001; 126:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/58\">",
"      Palm M, Moneret-Vautrin DA, Kanny G, et al. Food allergy to egg and soy lecithins. Allergy 1999; 54:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/59\">",
"      Awazuhara H, Kawai H, Baba M, et al. Antigenicity of the proteins in soy lecithin and soy oil in soybean allergy. Clin Exp Allergy 1998; 28:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/60\">",
"      Bernhisel-Broadbent J, Taylor S, Sampson HA. Cross-allergenicity in the legume botanical family in children with food hypersensitivity. II. Laboratory correlates. J Allergy Clin Immunol 1989; 84:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/61\">",
"      Ylitalo L, M&auml;kinen-Kiljunen S, Turjanmaa K, et al. Cow's milk casein, a hidden allergen in natural rubber latex gloves. J Allergy Clin Immunol 1999; 104:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/62\">",
"      Artesani MC, Donnanno S, Cavagni G, et al. Egg sensitization caused by immediate hypersensitivity reaction to drug-containing lysozyme. Ann Allergy Asthma Immunol 2008; 101:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/63\">",
"      Codreanu F, Morisset M, Cordebar V, et al. Risk of allergy to food proteins in topical medicinal agents and cosmetics. Eur Ann Allergy Clin Immunol 2006; 38:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/64\">",
"      Wang J, Nowak-Wegrzyn A. Reactions of 2 young children with milk allergy after cutaneous exposure to milk-containing cosmetic products. Arch Pediatr Adolesc Med 2004; 158:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/65\">",
"      Hallett R, Haapanen LA, Teuber SS. Food allergies and kissing. N Engl J Med 2002; 346:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/66\">",
"      Eriksson NE, M&ouml;ller C, Werner S, et al. The hazards of kissing when you are food allergic. A survey on the occurrence of kiss-induced allergic reactions among 1139 patients with self-reported food hypersensitivity. J Investig Allergol Clin Immunol 2003; 13:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/67\">",
"      Maloney JM, Chapman MD, Sicherer SH. Peanut allergen exposure through saliva: assessment and interventions to reduce exposure. J Allergy Clin Immunol 2006; 118:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/68\">",
"      W&uuml;thrich B, D&auml;scher M, Borelli S. Kiss-induced allergy to peanut. Allergy 2001; 56:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/48/18185/abstract/69\">",
"      Jacobs JF, Baumert JL, Brons PP, et al. Anaphylaxis from passive transfer of peanut allergen in a blood product. N Engl J Med 2011; 364:1981.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2406 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-71969A6E96-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18185=[""].join("\n");
var outline_f17_48_18185=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      How strict must avoidance be?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Skin contact and inhalation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22789097\">",
"      Maternal dietary avoidance of allergens for infants with proven food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SKILLS FOR DAILY LIVING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Food labeling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Legislation in the United States",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Legislation in other countries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Advisory labeling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Alcoholic beverages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Home meal preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cleaning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Restaurant meals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Airline travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      FOOD ALLERGENS IN NON-FOOD ITEMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Vaccines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Medications and asthma inhalers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Lactose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Soy lecithin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Casein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Egg lysozyme",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Cosmetics and crafts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      INTERPERSONAL CONTACT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Saliva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Other bodily fluids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2406\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2406|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/5/37980\" title=\"table 1\">",
"      Ingredient label terms for milk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/56/8076\" title=\"table 2\">",
"      Ingredient label terms for egg",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/41/32412\" title=\"table 3\">",
"      Ingredient label terms for peanut",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/25/29084\" title=\"table 4\">",
"      Ingredient label terms for wheat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/44/15052\" title=\"table 5\">",
"      Ingredient label terms for soy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/13/221\" title=\"table 6\">",
"      Ingredient label terms for tree nut",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/43/35516\" title=\"table 7\">",
"      Ingredient label terms for shellfish",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/38/14955\" title=\"table 8\">",
"      Allergen avoidance restaurants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/5/43097?source=related_link\">",
"      Allergic reactions to vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13223?source=related_link\">",
"      Egg allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/63/2042?source=related_link\">",
"      Food allergens: Overview of clinical features and cross-reactivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/39/3705?source=related_link\">",
"      Food allergy in schools and camps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/12/2250?source=related_link\">",
"      Food protein-induced enterocolitis syndrome (FPIES)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34631?source=related_link\">",
"      Food protein-induced proctitis/colitis and enteropathy of infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/30/20967?source=related_link\">",
"      Influenza vaccination in individuals with egg allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37430?source=related_link\">",
"      Management and prognosis of oral allergy syndrome (pollen-food allergy syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/9/40087?source=related_link\">",
"      Milk allergy: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23433?source=related_link\">",
"      Molecular features of food allergens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7993?source=related_link\">",
"      Nutritional issues in food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/42/43689?source=related_link\">",
"      Pathogenesis of food allergy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/35/35379?source=related_link\">",
"      Patient information: Food allergy treatment and avoidance (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20119?source=related_link\">",
"      Primary prevention of allergic disease: Maternal avoidance diets in pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/61/16346?source=related_link\">",
"      Seafood allergies: Fish and shellfish",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_48_18186="Classic juvenile pityriasis rubra pilaris";
var content_f17_48_18186=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87152%7EDERM%2F87153%7EDERM%2F87154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87152%7EDERM%2F87153%7EDERM%2F87154&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Classic juvenile pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 431px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Classical juvenile-onset pityriasis rubra pilaris (type III), presenting with hyperkeratotic red to orange follicular papules and plaques, with characteristic areas (islands) of uninvolved skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic juvenile pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hyperkeratotic red to orange follicular papules and plaques are on the legs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Classic juvenile pityriasis rubra pilaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 431px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Characteristic pityriasiform scaling is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18186=[""].join("\n");
var outline_f17_48_18186=null;
var title_f17_48_18187="Prevention indoor infestation";
var content_f17_48_18187=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F72595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F72595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevention of indoor fire ant infestation at health care facilities",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Determine if facility's pest service contract covers fire ants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vigilance to identify fire ant infestation should be increased during weather extremes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not allow beds or linens to touch the wall or floor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limit food in the bed as much as possible",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Check mattresses for food accumulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Place food left in the room in a well-sealed (air tight) container",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keep the outside of intravenous inserts as dry as possible",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Make sure that catheters are properly functioning",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid accumulation of water or food particles under base plates during floor sweeping or mopping",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goddard J, Jarratt J, deShazo RD. Recommendations for prevention and management of fire ant infestation of health care facilities. South Med J 2002; 95:627. Copyright &copy; 2002 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18187=[""].join("\n");
var outline_f17_48_18187=null;
var title_f17_48_18188="Major causes of type 1 RTA";
var content_f17_48_18188=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F56437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F56437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of type 1 (distal) renal tubular acidosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Primary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic (sporadic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Familial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Autosomal dominant (mainly due to mutations causing defects in the kidney anion exchanger - kAE1 in distal tubule intercalated cells)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Autosomal recessive (mainly due to mutations causing defects in V-ATPase in distal tubule intercalated cells)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Secondary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Autoimmune disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sj&ouml;gren's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Autoimmune hepatitis/Primary biliary cirrhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Systemic lupus erythematosus (may be hyperkalemic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ifosfamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Amphotericin B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lithium carbonate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Toluene inhalation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Hypercalciuric conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hyperparathyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Vitamin D intoxication",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Idiopathic hypercalciuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Medullary sponge kidney",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Obstructive uropathy (may be hyperkalemic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Renal transplant rejection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Wilson's disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18188=[""].join("\n");
var outline_f17_48_18188=null;
var title_f17_48_18189="Thrombocytopenia in pregnancy clinical features";
var content_f17_48_18189=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F53727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F53727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features and diagnosis of thrombocytopenic conditions in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disorder",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset during pregnancy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudothrombocytopenia",
"       </td>",
"       <td>",
"        Anytime",
"       </td>",
"       <td>",
"        Examine blood smear for platelet clumps, or giant platelets. Repeat platelet count in citrate or heparin anticoagulant. Usually caused by agglutinins dependent upon EDTA, the standard anticoagulant for blood counts.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Gestational thrombocytopenia",
"       </td>",
"       <td>",
"        Typically late in gestation, frequency increases as term approaches",
"       </td>",
"       <td>",
"        Based on five criteria:",
"        <ol>",
"         <li>",
"          Mild thrombocytopenia (most &gt;100,000/microL, rarely &lt;70,000/microL)",
"         </li>",
"         <li>",
"          No thrombocytopenia outside of pregnancy",
"         </li>",
"         <li>",
"          Occurs late in gestation",
"         </li>",
"         <li>",
"          No fetal/neonatal thrombocytopenia",
"         </li>",
"         <li>",
"          Postpartum resolution",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Immune thrombocytopenic purpura",
"       </td>",
"       <td>",
"        Anytime",
"       </td>",
"       <td>",
"        Presence of isolated thrombocytopenia with no evidence for alternative etiologies. May be indistinguishable from gestational thrombocytopenia if mild and occurs late during pregnancy. Platelet count may improve after delivery.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Preeclampsia",
"       </td>",
"       <td>",
"        After 20 weeks gestation",
"       </td>",
"       <td>",
"        Systolic or diastolic hypertension plus proteinuria",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        HELLP syndrome",
"       </td>",
"       <td>",
"        After 20 weeks gestation",
"       </td>",
"       <td>",
"        <p>",
"         Diagnostic criteria for preeclampsia are present in 85 percent of cases.",
"        </p>",
"        <p>",
"         Hemolysis: Microangiopathic hemolytic anemia with schistocytes, with other signs of hemolysis: increase serum LDH and indirect bilirubin, decreased haptoglobin",
"        </p>",
"        <p>",
"         Elevated liver function tests: Serum AST &ge;70 international units/L",
"        </p>",
"        <p>",
"         Low platelets: Platelet count &le;100,000/microL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        TTP/HUS",
"       </td>",
"       <td>",
"        Typically late in gestation, frequency increases as term approaches. May occur after delivery.",
"       </td>",
"       <td>",
"        Thrombocytopenia and microangiopathic hemolytic anemia without an alternative etiology. May be indistinguishable from severe preeclampsia or HELLP syndrome. Severe neurologic abnormalities and acute renal failure support the diagnosis of TTP/HUS. Persistent abnormalities &ge;3 days after delivery also support the diagnosis of TTP/HUS.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Drug-induced immune thrombocytopenia (except heparin)",
"       </td>",
"       <td>",
"        Anytime",
"       </td>",
"       <td>",
"        Complete history of drug ingestion, including non-prescription drugs and herbal remedies. Focus on drugs taken intermittently, or regularly for more than one week. Thrombocytopenia typically resolves in five to seven days after stopping the drug.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Heparin-induced thrombocytopenia",
"       </td>",
"       <td>",
"        Anytime",
"       </td>",
"       <td>",
"        <p>",
"         Suspected in patients who have thrombocytopenia (or &gt;50 percent decrease in platelet count) and who have begun heparin within previous 5 to 10 days.",
"        </p>",
"        <p>",
"         Thrombocytopenia is typically mild; arterial or venous thrombi are commonly present. ELISA assay for heparin-dependent antibodies is sensitive; measurement of heparin-induced platelet serotonin release is more specific.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Antiphospholipid syndrome",
"       </td>",
"       <td>",
"        Anytime",
"       </td>",
"       <td>",
"        <p>",
"         Requires one clinical and one laboratory criterion:",
"        </p>",
"        <strong>",
"         Clinical:",
"        </strong>",
"        <ol>",
"         <li>",
"          Thrombocytopenia",
"         </li>",
"         <li>",
"          Adverse pregnancy outcome: &ge;3 losses &lt;10 weeks gestation or &ge;1 loss &ge;10 weeks gestation, &lt;34 week delivery secondary to preeclampsia or placental insufficiency",
"         </li>",
"         <li>",
"          Arterial or venous thrombosis",
"         </li>",
"        </ol>",
"        <br/>",
"        <p>",
"         <strong>",
"          Laboratory:",
"         </strong>",
"        </p>",
"        Demonstration of the persistent presence of at least one of the following antiphospholipid antibodies:",
"        <ol>",
"         <li>",
"          Lupus anticoagulant",
"         </li>",
"         <li>",
"          Anticardiolipin antibody",
"         </li>",
"         <li>",
"          Anti-&beta;2 glycoprotein-I",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James N George, MD and Eric J Knudtson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18189=[""].join("\n");
var outline_f17_48_18189=null;
var title_f17_48_18190="BP change and salt intake";
var content_f17_48_18190=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F81634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F81634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Blood pressure change and sodium reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 429px; height: 260px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pooled results from all sodium-reduction trials concerning the mean net change in blood pressure due to restrictions in sodium intake among various subsets of patients.",
"    <div class=\"footnotes\">",
"     SBP: systolic blood pressure; DBP: diastolic blood pressure.",
"     <br>",
"      * The mean change is compared with control values.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Cutler JA, Follmann D, Allender PS. Am J Clin Nutr 1997; 65:643S.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18190=[""].join("\n");
var outline_f17_48_18190=null;
var title_f17_48_18191="Risk of various aneuplodies by maternal age";
var content_f17_48_18191=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F50590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F50590&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk of various aneuplodies by maternal age, in rates per thousand",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Maternal age",
"       </td>",
"       <td class=\"subtitle1\">",
"        Down syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Edwards syndrome (trisomy 18)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Patau syndrome (trisomy 13)",
"       </td>",
"       <td class=\"subtitle1\">",
"        XXY",
"       </td>",
"       <td class=\"subtitle1\">",
"        XYY",
"       </td>",
"       <td class=\"subtitle1\">",
"        Turner syndrome genotype",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other clinically significant abnormality*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Total",
"        <span class=\"small\">",
"         &bull;",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;15",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        &lt;0.1&Delta;",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        0.9",
"       </td>",
"       <td>",
"        &lt;0.1&Delta;",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        &lt;0.1&Delta;",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        &lt;0.1&Delta;",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        &lt;0.1&Delta;",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        1.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        0.5-0.7",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        0.5-0.7",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        1.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        0.6-0.8",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        0.6-0.8",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        0.7-0.9",
"       </td>",
"       <td>",
"        0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        0.7-0.9",
"       </td>",
"       <td>",
"        0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        0.7-1.0",
"       </td>",
"       <td>",
"        0.1-0.1",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        0.8-1.0",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        &lt;0.1-0.1",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        28",
"       </td>",
"       <td>",
"        0.8-1.1",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        &lt;0.1-0.2",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        0.8-1.2",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        &lt;0.1-0.2",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        0.9-1.2",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        &lt;0.1-0.2",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        0.9-1.3",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        &lt;0.1-0.2",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        1.1-1.5",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        3.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        1.4-1.9",
"       </td>",
"       <td>",
"        0.1-0.3",
"       </td>",
"       <td>",
"        0.1-0.2",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        3.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        1.9-2.4",
"       </td>",
"       <td>",
"        0.2-0.4",
"       </td>",
"       <td>",
"        0.1-0.3",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        4.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        2.5-3.9",
"       </td>",
"       <td>",
"        0.3-0.5",
"       </td>",
"       <td>",
"        0.2-0.3",
"       </td>",
"       <td>",
"        0.9",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        5.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        3.2-5.0",
"       </td>",
"       <td>",
"        0.3-0.6",
"       </td>",
"       <td>",
"        0.2-0.4",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        6.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        37",
"       </td>",
"       <td>",
"        4.1-6.4",
"       </td>",
"       <td>",
"        0.4-0.7",
"       </td>",
"       <td>",
"        0.2-0.5",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        8.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        5.2-8.1",
"       </td>",
"       <td>",
"        0.5-0.9",
"       </td>",
"       <td>",
"        0.3-0.7",
"       </td>",
"       <td>",
"        1.3",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        9.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        39",
"       </td>",
"       <td>",
"        6.6-10.5",
"       </td>",
"       <td>",
"        0.7-1.2",
"       </td>",
"       <td>",
"        0.4-0.8",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        12.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        8.5-13.7",
"       </td>",
"       <td>",
"        0.9-1.6",
"       </td>",
"       <td>",
"        0.5-1.1",
"       </td>",
"       <td>",
"        1.8",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        15.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        41",
"       </td>",
"       <td>",
"        10.8-17.9",
"       </td>",
"       <td>",
"        1.1-2.1",
"       </td>",
"       <td>",
"        0.6-1.4",
"       </td>",
"       <td>",
"        2.2",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        20.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        13.8-23.4",
"       </td>",
"       <td>",
"        1.4-2.7",
"       </td>",
"       <td>",
"        0.7-1.8",
"       </td>",
"       <td>",
"        2.7",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        25.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        17.6-30.6",
"       </td>",
"       <td>",
"        1.8-3.5",
"       </td>",
"       <td>",
"        0.9-2.4",
"       </td>",
"       <td>",
"        3.3",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        32.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        22.5-40.0",
"       </td>",
"       <td>",
"        2.3-4.6",
"       </td>",
"       <td>",
"        1.2-3.1",
"       </td>",
"       <td>",
"        4.1",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        41.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        45",
"       </td>",
"       <td>",
"        28.7-52.3",
"       </td>",
"       <td>",
"        2.9-6.0",
"       </td>",
"       <td>",
"        1.5-4.1",
"       </td>",
"       <td>",
"        5.1",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        53.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        46",
"       </td>",
"       <td>",
"        36.6-68.3",
"       </td>",
"       <td>",
"        3.7-7.9",
"       </td>",
"       <td>",
"        1.9-5.3",
"       </td>",
"       <td>",
"        6.4",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        68.9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        47",
"       </td>",
"       <td>",
"        46.6-89.3",
"       </td>",
"       <td>",
"        4.7-10.3",
"       </td>",
"       <td>",
"        2.4-6.9",
"       </td>",
"       <td>",
"        8.2",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        89.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        59.5-116.8",
"       </td>",
"       <td>",
"        6.0-13.5",
"       </td>",
"       <td>",
"        3.0-9.0",
"       </td>",
"       <td>",
"        10.6",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        115.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        75.8-152.7",
"       </td>",
"       <td>",
"        7.6-17.6",
"       </td>",
"       <td>",
"        3.8-11.8",
"       </td>",
"       <td>",
"        13.8",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        &lt;0.1",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        149.3",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * XXX is excluded.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Calculation of the total at each age assumes rate for autosomal aneuploidies is at the midpoints of the ranges given.",
"      <br>",
"       &Delta; No range may be constructed for those under 20 years by the same methods as for those 20 and over.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981; 58:282. Copyright &copy; 1981 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_48_18191=[""].join("\n");
var outline_f17_48_18191=null;
